{\rtf1\adeflang1025\ansi\ansicpg1252\uc1\adeff31507\deff0\stshfdbch31505\stshfloch31506\stshfhich31506\stshfbi31507\deflang1033\deflangfe1042\themelang1033\themelangfe1042\themelangcs0{\fonttbl{\f0\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f2\fbidi \fmodern\fcharset0\fprq1{\*\panose 02070309020205020404}Courier New;}
{\f3\fbidi \fdecor\fcharset2\fprq2{\*\panose 05050102010706020507}Symbol;}{\f10\fbidi \fdecor\fcharset77\fprq2{\*\panose 05000000000000000000}Wingdings;}{\f34\fbidi \froman\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria Math;}
{\f42\fbidi \fswiss\fcharset129\fprq2{\*\panose 020b0503020000020004}Malgun Gothic{\*\falt \'b8\'bc\'c0\'ba \'b0\'ed\'b5\'f1};}{\f44\fbidi \fswiss\fcharset0\fprq2{\*\panose 020b0004020202020204}Aptos;}
{\f45\fbidi \froman\fcharset0\fprq0{\*\panose 020b0604020202020204}"Arial",sans-serif{\*\falt Cambria};}{\f1570\fbidi \fswiss\fcharset129\fprq2 @Malgun Gothic;}
{\flomajor\f31500\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fdbmajor\f31501\fbidi \fswiss\fcharset129\fprq2{\*\panose 020b0503020000020004}Malgun Gothic{\*\falt \'b8\'bc\'c0\'ba \'b0\'ed\'b5\'f1};}
{\fhimajor\f31502\fbidi \fswiss\fcharset0\fprq2{\*\panose 020b0004020202020204}Aptos Display;}{\fbimajor\f31503\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}
{\flominor\f31504\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fdbminor\f31505\fbidi \fswiss\fcharset129\fprq2{\*\panose 020b0503020000020004}Malgun Gothic{\*\falt \'b8\'bc\'c0\'ba \'b0\'ed\'b5\'f1};}
{\fhiminor\f31506\fbidi \fswiss\fcharset0\fprq2{\*\panose 020b0004020202020204}Aptos;}{\fbiminor\f31507\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f1571\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}
{\f1572\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\f1574\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\f1575\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\f1576\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}
{\f1577\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\f1578\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\f1579\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}
{\f1591\fbidi \fmodern\fcharset238\fprq1 Courier New CE;}{\f1592\fbidi \fmodern\fcharset204\fprq1 Courier New Cyr;}{\f1594\fbidi \fmodern\fcharset161\fprq1 Courier New Greek;}{\f1595\fbidi \fmodern\fcharset162\fprq1 Courier New Tur;}
{\f1596\fbidi \fmodern\fcharset177\fprq1 Courier New (Hebrew);}{\f1597\fbidi \fmodern\fcharset178\fprq1 Courier New (Arabic);}{\f1598\fbidi \fmodern\fcharset186\fprq1 Courier New Baltic;}{\f1599\fbidi \fmodern\fcharset163\fprq1 Courier New (Vietnamese);}
{\f1911\fbidi \froman\fcharset238\fprq2 Cambria Math CE;}{\f1912\fbidi \froman\fcharset204\fprq2 Cambria Math Cyr;}{\f1914\fbidi \froman\fcharset161\fprq2 Cambria Math Greek;}{\f1915\fbidi \froman\fcharset162\fprq2 Cambria Math Tur;}
{\f1918\fbidi \froman\fcharset186\fprq2 Cambria Math Baltic;}{\f1919\fbidi \froman\fcharset163\fprq2 Cambria Math (Vietnamese);}{\f1993\fbidi \fswiss\fcharset0\fprq2 Malgun Gothic Western{\*\falt \'b8\'bc\'c0\'ba \'b0\'ed\'b5\'f1};}
{\f2011\fbidi \fswiss\fcharset238\fprq2 Aptos CE;}{\f2012\fbidi \fswiss\fcharset204\fprq2 Aptos Cyr;}{\f2014\fbidi \fswiss\fcharset161\fprq2 Aptos Greek;}{\f2015\fbidi \fswiss\fcharset162\fprq2 Aptos Tur;}
{\f2018\fbidi \fswiss\fcharset186\fprq2 Aptos Baltic;}{\f2019\fbidi \fswiss\fcharset163\fprq2 Aptos (Vietnamese);}{\f17273\fbidi \fswiss\fcharset0\fprq2 @Malgun Gothic Western;}{\flomajor\f31508\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}
{\flomajor\f31509\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\flomajor\f31511\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\flomajor\f31512\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}
{\flomajor\f31513\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\flomajor\f31514\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\flomajor\f31515\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}
{\flomajor\f31516\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fdbmajor\f31520\fbidi \fswiss\fcharset0\fprq2 Malgun Gothic Western{\*\falt \'b8\'bc\'c0\'ba \'b0\'ed\'b5\'f1};}
{\fhimajor\f31528\fbidi \fswiss\fcharset238\fprq2 Aptos Display CE;}{\fhimajor\f31529\fbidi \fswiss\fcharset204\fprq2 Aptos Display Cyr;}{\fhimajor\f31531\fbidi \fswiss\fcharset161\fprq2 Aptos Display Greek;}
{\fhimajor\f31532\fbidi \fswiss\fcharset162\fprq2 Aptos Display Tur;}{\fhimajor\f31535\fbidi \fswiss\fcharset186\fprq2 Aptos Display Baltic;}{\fhimajor\f31536\fbidi \fswiss\fcharset163\fprq2 Aptos Display (Vietnamese);}
{\fbimajor\f31538\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\fbimajor\f31539\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\fbimajor\f31541\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}
{\fbimajor\f31542\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\fbimajor\f31543\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbimajor\f31544\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}
{\fbimajor\f31545\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\fbimajor\f31546\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\flominor\f31548\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}
{\flominor\f31549\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\flominor\f31551\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\flominor\f31552\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}
{\flominor\f31553\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\flominor\f31554\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\flominor\f31555\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}
{\flominor\f31556\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fdbminor\f31560\fbidi \fswiss\fcharset0\fprq2 Malgun Gothic Western{\*\falt \'b8\'bc\'c0\'ba \'b0\'ed\'b5\'f1};}{\fhiminor\f31568\fbidi \fswiss\fcharset238\fprq2 Aptos CE;}
{\fhiminor\f31569\fbidi \fswiss\fcharset204\fprq2 Aptos Cyr;}{\fhiminor\f31571\fbidi \fswiss\fcharset161\fprq2 Aptos Greek;}{\fhiminor\f31572\fbidi \fswiss\fcharset162\fprq2 Aptos Tur;}{\fhiminor\f31575\fbidi \fswiss\fcharset186\fprq2 Aptos Baltic;}
{\fhiminor\f31576\fbidi \fswiss\fcharset163\fprq2 Aptos (Vietnamese);}{\fbiminor\f31578\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\fbiminor\f31579\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}
{\fbiminor\f31581\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\fbiminor\f31582\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\fbiminor\f31583\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}
{\fbiminor\f31584\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\fbiminor\f31585\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\fbiminor\f31586\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}}
{\colortbl;\red0\green0\blue0;\red0\green0\blue255;\red0\green255\blue255;\red0\green255\blue0;\red255\green0\blue255;\red255\green0\blue0;\red255\green255\blue0;\red255\green255\blue255;\red0\green0\blue128;\red0\green128\blue128;\red0\green128\blue0;
\red128\green0\blue128;\red128\green0\blue0;\red128\green128\blue0;\red128\green128\blue128;\red192\green192\blue192;\red0\green0\blue0;\red0\green0\blue0;\caccentone\ctint255\cshade191\red15\green71\blue97;
\ctextone\ctint166\cshade255\red89\green89\blue89;\ctextone\ctint216\cshade255\red39\green39\blue39;\ctextone\ctint191\cshade255\red64\green64\blue64;\red249\green250\blue251;\red247\green247\blue248;\red15\green15\blue15;\red31\green41\blue55;}
{\*\defchp \fs24\kerning2\loch\af31506\hich\af31506\dbch\af31505 }{\*\defpap \ql \li0\ri0\sa160\sl278\slmult1\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 }\noqfpromote {\stylesheet{\ql \li0\ri0\sa160\sl278\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 \fs24\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 
\snext0 \sqformat \spriority0 Normal;}{\s1\ql \li0\ri0\sb360\sa80\sl278\slmult1\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel0\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs40\alang1025 \ltrch\fcs0 
\fs40\cf19\lang1033\langfe1042\kerning2\loch\f31502\hich\af31502\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink15 \sqformat \spriority9 \styrsid15621951 heading 1;}{\s2\ql \li0\ri0\sb160\sa80\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel1\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs32\alang1025 \ltrch\fcs0 
\fs32\cf19\lang1033\langfe1042\kerning2\loch\f31502\hich\af31502\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink16 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 2;}{\s3\ql \li0\ri0\sb160\sa80\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel2\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs28\alang1025 \ltrch\fcs0 
\fs28\cf19\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink17 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 3;}{\s4\ql \li0\ri0\sb80\sa40\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel3\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \ai\af31503\afs24\alang1025 \ltrch\fcs0 
\i\fs24\cf19\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink18 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 4;}{\s5\ql \li0\ri0\sb80\sa40\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel4\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs24\alang1025 \ltrch\fcs0 
\fs24\cf19\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink19 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 5;}{\s6\ql \li0\ri0\sb40\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel5\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \ai\af31503\afs24\alang1025 \ltrch\fcs0 
\i\fs24\cf20\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink20 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 6;}{\s7\ql \li0\ri0\sb40\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel6\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs24\alang1025 \ltrch\fcs0 
\fs24\cf20\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink21 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 7;}{\s8\ql \li0\ri0\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel7\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \ai\af31503\afs24\alang1025 \ltrch\fcs0 
\i\fs24\cf21\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink22 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 8;}{\s9\ql \li0\ri0\sl278\slmult1
\keep\keepn\widctlpar\wrapdefault\aspalpha\aspnum\faauto\outlinelevel8\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs24\alang1025 \ltrch\fcs0 
\fs24\cf21\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink23 \ssemihidden \sunhideused \sqformat \spriority9 \styrsid15621951 heading 9;}{\*\cs10 \additive 
\ssemihidden \sunhideused \spriority1 Default Paragraph Font;}{\*\ts11\tsrowd\trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\tblind0\tblindtype3\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv 
\ql \li0\ri0\sa160\sl278\slmult1\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 \snext11 \ssemihidden \sunhideused Normal Table;}{\*\cs15 \additive \rtlch\fcs1 \af31503\afs40 \ltrch\fcs0 
\fs40\cf19\loch\f31502\hich\af31502\dbch\af31501 \sbasedon10 \slink1 \spriority9 \styrsid15621951 Heading 1 Char;}{\*\cs16 \additive \rtlch\fcs1 \af31503\afs32 \ltrch\fcs0 \fs32\cf19\loch\f31502\hich\af31502\dbch\af31501 
\sbasedon10 \slink2 \ssemihidden \spriority9 \styrsid15621951 Heading 2 Char;}{\*\cs17 \additive \rtlch\fcs1 \af31503\afs28 \ltrch\fcs0 \fs28\cf19\dbch\af31501 \sbasedon10 \slink3 \ssemihidden \spriority9 \styrsid15621951 Heading 3 Char;}{\*\cs18 
\additive \rtlch\fcs1 \ai\af31503 \ltrch\fcs0 \i\cf19\dbch\af31501 \sbasedon10 \slink4 \ssemihidden \spriority9 \styrsid15621951 Heading 4 Char;}{\*\cs19 \additive \rtlch\fcs1 \af31503 \ltrch\fcs0 \cf19\dbch\af31501 
\sbasedon10 \slink5 \ssemihidden \spriority9 \styrsid15621951 Heading 5 Char;}{\*\cs20 \additive \rtlch\fcs1 \ai\af31503 \ltrch\fcs0 \i\cf20\dbch\af31501 \sbasedon10 \slink6 \ssemihidden \spriority9 \styrsid15621951 Heading 6 Char;}{\*\cs21 \additive 
\rtlch\fcs1 \af31503 \ltrch\fcs0 \cf20\dbch\af31501 \sbasedon10 \slink7 \ssemihidden \spriority9 \styrsid15621951 Heading 7 Char;}{\*\cs22 \additive \rtlch\fcs1 \ai\af31503 \ltrch\fcs0 \i\cf21\dbch\af31501 
\sbasedon10 \slink8 \ssemihidden \spriority9 \styrsid15621951 Heading 8 Char;}{\*\cs23 \additive \rtlch\fcs1 \af31503 \ltrch\fcs0 \cf21\dbch\af31501 \sbasedon10 \slink9 \ssemihidden \spriority9 \styrsid15621951 Heading 9 Char;}{
\s24\ql \li0\ri0\sa80\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\contextualspace \rtlch\fcs1 \af31503\afs56\alang1025 \ltrch\fcs0 
\fs56\expnd-2\expndtw-10\lang1033\langfe1042\kerning28\loch\f31502\hich\af31502\dbch\af31501\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink25 \sqformat \spriority10 \styrsid15621951 Title;}{\*\cs25 \additive \rtlch\fcs1 \af31503\afs56 
\ltrch\fcs0 \fs56\expnd-2\expndtw-10\kerning28\loch\f31502\hich\af31502\dbch\af31501 \sbasedon10 \slink24 \spriority10 \styrsid15621951 Title Char;}{\s26\ql \li0\ri0\sa160\sl278\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ilvl1\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31503\afs28\alang1025 \ltrch\fcs0 \fs28\expnd3\expndtw15\cf20\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31501\cgrid\langnp1033\langfenp1042 
\sbasedon0 \snext0 \slink27 \sqformat \spriority11 \styrsid15621951 Subtitle;}{\*\cs27 \additive \rtlch\fcs1 \af31503\afs28 \ltrch\fcs0 \fs28\expnd3\expndtw15\cf20\dbch\af31501 \sbasedon10 \slink26 \spriority11 \styrsid15621951 Subtitle Char;}{
\s28\qc \li0\ri0\sb160\sa160\sl278\slmult1\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \ai\af31507\afs24\alang1025 \ltrch\fcs0 
\i\fs24\cf22\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext0 \slink29 \sqformat \spriority29 \styrsid15621951 Quote;}{\*\cs29 \additive \rtlch\fcs1 \ai\af0 \ltrch\fcs0 \i\cf22 
\sbasedon10 \slink28 \spriority29 \styrsid15621951 Quote Char;}{\s30\ql \li720\ri0\sa160\sl278\slmult1\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin720\itap0\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext30 \sqformat \spriority34 \styrsid15621951 List Paragraph;}{\*\cs31 \additive \rtlch\fcs1 \ai\af0 \ltrch\fcs0 \i\cf19 
\sbasedon10 \sqformat \spriority21 \styrsid15621951 Intense Emphasis;}{\s32\qc \li864\ri864\sb360\sa360\sl278\slmult1\widctlpar\brdrt\brdrs\brdrw10\brsp200\brdrcf19 \brdrb\brdrs\brdrw10\brsp200\brdrcf19 
\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin864\lin864\itap0 \rtlch\fcs1 \ai\af31507\afs24\alang1025 \ltrch\fcs0 \i\fs24\cf19\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 
\sbasedon0 \snext0 \slink33 \sqformat \spriority30 \styrsid15621951 Intense Quote;}{\*\cs33 \additive \rtlch\fcs1 \ai\af0 \ltrch\fcs0 \i\cf19 \sbasedon10 \slink32 \spriority30 \styrsid15621951 Intense Quote Char;}{\*\cs34 \additive \rtlch\fcs1 \ab\af0 
\ltrch\fcs0 \b\scaps\expnd1\expndtw5\cf19 \sbasedon10 \sqformat \spriority32 \styrsid15621951 Intense Reference;}{\*\ts35\tsrowd\trbrdrt\brdrs\brdrw10 \trbrdrl\brdrs\brdrw10 \trbrdrb\brdrs\brdrw10 \trbrdrr\brdrs\brdrw10 \trbrdrh\brdrs\brdrw10 \trbrdrv
\brdrs\brdrw10 \trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\tblind0\tblindtype3\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv 
\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 \f31506\fs24\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \sbasedon11 \snext35 \spriority39 \styrsid15621951 
Table Grid;}{\s36\ql \li0\ri0\widctlpar\tqc\tx4680\tqr\tx9360\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext36 \slink37 \sunhideused \styrsid15621951 header;}{\*\cs37 \additive \rtlch\fcs1 \af0 \ltrch\fcs0 
\sbasedon10 \slink36 \styrsid15621951 Header Char;}{\s38\ql \li0\ri0\widctlpar\tqc\tx4680\tqr\tx9360\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 \sbasedon0 \snext38 \slink39 \sunhideused \styrsid15621951 footer;}{\*\cs39 \additive \rtlch\fcs1 \af0 \ltrch\fcs0 
\sbasedon10 \slink38 \styrsid15621951 Footer Char;}}{\*\listtable{\list\listtemplateid1919986880\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698703
\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698713
\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715
\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703
\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713
\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715
\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703
\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713
\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715
\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid20208952}{\list\listtemplateid2135444054\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1
\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0
\levelindent0{\leveltext\leveltemplateid67698713\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698715\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698703\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698713\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698715\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698703\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698713\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698715\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid79716110}{\list\listtemplateid-1528630692\listhybrid{\listlevel\levelnfc0\levelnfcn0
\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0
\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2
\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0
\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0
\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2
\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0
\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0
\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2
\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid357706654}
{\list\listtemplateid-1548580356\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid612520757}{\list\listtemplateid-621362938\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid2033238272
\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1663675354
\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1837744718
\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1233435678
\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid2027309342
\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1555443406
\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-339693136
\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1096059522
\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid969335604
\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid874825813}{\list\listtemplateid-32106342\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1
\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0
\levelindent0{\leveltext\leveltemplateid67698713\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698715\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698703\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698713\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698715\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698703\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698713\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0
\levelindent0{\leveltext\leveltemplateid67698715\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid1041636041}{\list\listtemplateid-2581188\listhybrid{\listlevel\levelnfc0\levelnfcn0
\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1855860540\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0
\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1882840134\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2
\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid436502196\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0
\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid961073130\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1
\levelspace0\levelindent0{\leveltext\leveltemplateid-570939540\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0
\levelindent0{\leveltext\leveltemplateid-1099637976\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0
{\leveltext\leveltemplateid199908174\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext
\leveltemplateid1402873550\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext
\leveltemplateid-194760280\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid1129353023}{\list\listtemplateid-479585608\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0
\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1329276502\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \b\fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0
\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0
\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid1301232426}{\list\listtemplateid-1422623176
\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \fbias0\hres0\chhres0 \fi-360\li720\lin720 }
{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel
\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel
\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel
\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel
\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel
\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel
\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel
\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname 
;}\listid1402798284}{\list\listtemplateid1343374272\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1946039686\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 
\ltrch\fcs0 \hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1257973978\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 
\hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1942651918\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1582367576\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1778839740\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid383537338\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid2127045956\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-424642980\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid534787398\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 
\fi-180\li6480\lin6480 }{\listname ;}\listid1445463796}{\list\listtemplateid2015662876\listhybrid{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698703
\'02\'00.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid67698713
\'02\'01.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715
\'02\'02.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li2160\lin2160 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703
\'02\'03.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713
\'02\'04.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li3600\lin3600 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715
\'02\'05.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li4320\lin4320 }{\listlevel\levelnfc0\levelnfcn0\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698703
\'02\'06.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698713
\'02\'07.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc2\levelnfcn2\leveljc2\leveljcn2\levelfollow0\levelstartat1\lvltentative\levelspace0\levelindent0{\leveltext\leveltemplateid67698715
\'02\'08.;}{\levelnumbers\'01;}\rtlch\fcs1 \af0 \ltrch\fcs0 \hres0\chhres0 \fi-180\li6480\lin6480 }{\listname ;}\listid1594892522}{\list\listtemplateid-1797495288\listhybrid{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1
\levelspace0\levelindent0{\leveltext\leveltemplateid-883631326\'01-;}{\levelnumbers;}\f45\fbias0\hres0\chhres0 \fi-360\li720\lin720 }{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext
\leveltemplateid587353204\'01o;}{\levelnumbers;}\f2\fbias0\hres0\chhres0 \fi-360\li1440\lin1440 }{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1928325760
\'01\u-3929 _;}{\levelnumbers;}\f10\fbias0\hres0\chhres0 \fi-360\li2160\lin2160 }{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1309148766\'01\u-3913 _;}{\levelnumbers;}
\f3\fbias0\hres0\chhres0 \fi-360\li2880\lin2880 }{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1368751062\'01o;}{\levelnumbers;}\f2\fbias0\hres0\chhres0 
\fi-360\li3600\lin3600 }{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-958776230\'01\u-3929 _;}{\levelnumbers;}\f10\fbias0\hres0\chhres0 \fi-360\li4320\lin4320 }
{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid-1134929494\'01\u-3913 _;}{\levelnumbers;}\f3\fbias0\hres0\chhres0 \fi-360\li5040\lin5040 }{\listlevel\levelnfc23
\levelnfcn23\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid984529236\'01o;}{\levelnumbers;}\f2\fbias0\hres0\chhres0 \fi-360\li5760\lin5760 }{\listlevel\levelnfc23\levelnfcn23\leveljc0\leveljcn0
\levelfollow0\levelstartat1\levelspace0\levelindent0{\leveltext\leveltemplateid1463701528\'01\u-3929 _;}{\levelnumbers;}\f10\fbias0\hres0\chhres0 \fi-360\li6480\lin6480 }{\listname ;}\listid2086815185}}{\*\listoverridetable{\listoverride\listid874825813
\listoverridecount0\ls1}{\listoverride\listid1129353023\listoverridecount0\ls2}{\listoverride\listid2086815185\listoverridecount0\ls3}{\listoverride\listid1445463796\listoverridecount0\ls4}{\listoverride\listid1402798284\listoverridecount0\ls5}
{\listoverride\listid20208952\listoverridecount0\ls6}{\listoverride\listid79716110\listoverridecount0\ls7}{\listoverride\listid612520757\listoverridecount0\ls8}{\listoverride\listid1594892522\listoverridecount0\ls9}{\listoverride\listid1041636041
\listoverridecount0\ls10}{\listoverride\listid1301232426\listoverridecount0\ls11}{\listoverride\listid357706654\listoverridecount0\ls12}}{\*\rsidtbl \rsid752277\rsid2513918\rsid3569647\rsid4867355\rsid5902932\rsid9128502\rsid9778326\rsid10883573
\rsid11471096\rsid12595237\rsid13658469\rsid14228310\rsid14882082\rsid15621951\rsid16529641\rsid16580749}{\mmathPr\mmathFont34\mbrkBin0\mbrkBinSub0\msmallFrac0\mdispDef1\mlMargin0\mrMargin0\mdefJc1\mwrapIndent1440\mintLim0\mnaryLim1}{\info
{\author Hong, Soonwook MD}{\operator Hong, Soonwook MD}{\creatim\yr2026\mo2\dy26\hr16\min1}{\revtim\yr2026\mo2\dy26\hr16\min1}{\version2}{\edmins0}{\nofpages23}{\nofwords13387}{\nofchars42708}{\nofcharsws44877}{\vern3089}}{\*\xmlnstbl {\xmlns1 http://sch
emas.microsoft.com/office/word/2003/wordml}}\paperw12240\paperh15840\margl1440\margr1440\margt1440\margb1440\gutter0\ltrsect 
\widowctrl\ftnbj\aenddoc\trackmoves0\trackformatting1\donotembedsysfont1\relyonvml0\donotembedlingdata0\grfdocevents0\validatexml1\showplaceholdtext0\ignoremixedcontent0\saveinvalidxml0\showxmlerrors1\noxlattoyen
\expshrtn\noultrlspc\dntblnsbdb\nospaceforul\formshade\horzdoc\dgmargin\dghspace180\dgvspace180\dghorigin1440\dgvorigin1440\dghshow1\dgvshow1
\jexpand\viewkind1\viewscale159\pgbrdrhead\pgbrdrfoot\splytwnine\ftnlytwnine\htmautsp\nolnhtadjtbl\useltbaln\alntblind\lytcalctblwd\lyttblrtgr\lnbrkrule\nobrkwrptbl\snaptogridincell\allowfieldendsel\wrppunct
\asianbrkrule\rsidroot15621951\newtblstyruls\nogrowautofit\usenormstyforlist\noindnmbrts\felnbrelev\nocxsptable\indrlsweleven\noafcnsttbl\afelev\utinl\hwelev\spltpgpar\notcvasp\notbrkcnstfrctbl\notvatxbx\krnprsnet\cachedcolbal \nouicompat \fet0
{\*\wgrffmtfilter 2450}\nofeaturethrottle1\ilfomacatclnup0{\*\ftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af31507 \ltrch\fcs0 \insrsid14882082 \chftnsep 
\par }}{\*\ftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af31507 \ltrch\fcs0 \insrsid14882082 \chftnsepc 
\par }}{\*\aftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af31507 \ltrch\fcs0 \insrsid14882082 \chftnsep 
\par }}{\*\aftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af31507 \ltrch\fcs0 \insrsid14882082 \chftnsepc 
\par }}\ltrpar \sectd \ltrsect\linex0\endnhere\sectlinegrid360\sectdefaultcl\sftnbj {\*\pnseclvl1\pnucrm\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl2\pnucltr\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl3\pndec\pnstart1\pnindent720\pnhang 
{\pntxta .}}{\*\pnseclvl4\pnlcltr\pnstart1\pnindent720\pnhang {\pntxta )}}{\*\pnseclvl5\pndec\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl6\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl7
\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl8\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl9\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}\pard\plain \ltrpar
\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Case 1
\par }\pard \ltrpar\qj \li0\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI
\par \hich\af0\dbch\af31505\loch\f0 Lisa Roberts is a 28 year old woman with a known diagnosis of ulcerative colitis.
\par \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 2021 \hich\f0 \endash \loch\f0  \hich\af0\dbch\af31505\loch\f0 Presented with diarrhea, abdominal pain, hematochezia, colonoscopy with severe pancolitis. Started on Lialda with some improvement
\par \hich\af0\dbch\af31505\loch\f0 3/2022 \hich\f0 \endash \loch\f0  Repeat colonoscopy showed patchy inflammation in transverse colon, sigmoid, and rectum. Discussed biologic but patient wanted to defer. Tried enemas but did not tolerate well.
\par \hich\af0\dbch\af31505\loch\f0 5/2023 \hich\f0 \endash \loch\f0 
 Admitted to Palmsdale Presbyterian Hospital with worsening diarrhea, abdominal pain, fevers. CTAP showed pancolitis. Stool cultures were negative. Flexible sigmoidoscopy showed Mayo 3 colitis extending up to 45cm from the anal verge. There was no
\hich\af0\dbch\af31505\loch\f0  evidence of CMV on biopsies, but the picture was consistent with a severe flare of UC. Lisa received infliximab 10mg/kg during this admission on 5/5/23 and discharged on steroid taper.
\par \hich\af0\dbch\af31505\loch\f0 5/20/23 \hich\f0 \endash \loch\f0  Seen in GI clinic, she reports feeling very weak, still having diarrhea, no blood. She is taking prednisone 40mg daily but her symptoms are not under control.
\par \hich\af0\dbch\af31505\loch\f0 Today (5/25/23)
\par \hich\af0\dbch\af31505\loch\f0 \hich\f0 Despite being on infliximab and metronidazole, her symptoms have not improved. She is having up to 10 BMs daily, which are watery, and occasionally bloody. The fever persists, spiking to 101\'b0\loch\f0 
F at times. Her appetite is poor and she reports weight loss.
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2021
\par }\pard \ltrpar\qj \li0\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Outputs:
\par }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\qj \fi-360\li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls1\adjustright\rin-20\lin-20\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Lisa Roberts is a 28-year-old woman with a history of UC diagnosed 2021 with recent hospitalization for severe flare with initiation of infliximab and prednisone who is still having ongoing symptoms concerning for uncontrolled IBD. Concerningly, she prese
\hich\af0\dbch\af31505\loch\f0 
nted with fevers but initial infectious workup was negative. Would resend a full infectious workup including stool cultures including C diff PCR in case there is a superimposed infection that is being missed, also recommended to her that she go to the hos
\hich\af0\dbch\af31505\loch\f0 pi\hich\af0\dbch\af31505\loch\f0 tal for inpatient admission given here severe flare. Would also check an infliximab level. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Lisa Roberts, a 28-year-old female with a known diagnosis of ulcerative colitis, has been experiencing severely active symptoms since the onset of her disease in 2021. Despite being on Lialda and infliximab, her symptoms have not improved, and she has bee
\hich\af0\dbch\af31505\loch\f0 
n experiencing up to 10 watery, bloody bowel movements daily, along with fever and weight loss. Recent flexible sigmoidoscopy results showed Mayo 3 colitis extending up to 45cm from the anal verge, indicating severe activity of her ulcerative colitis. (Ll
\hich\af0\dbch\af31505\loch\f0 am\hich\af0\dbch\af31505\loch\f0 a-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat24\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Lisa Roberts, a 28-year-old woman, was diagnosed with ulcerative colitis in 2021, initially presenting with severe pancolitis. Despite treatment with Lialda and enemas, which she did not tolerate well, her disease has remained severely active, with her ex
\hich\af0\dbch\af31505\loch\f0 
periencing up to 10 bowel movements daily. Currently, she is on Infliximab, Metronidazole, and a daily dose of Prednisone (40mg). Recent diagnostics, including a flexible sigmoidoscopy in 5/2023, revealed Mayo 3 colitis up to 45cm from the anal verge, con
\hich\af0\dbch\af31505\loch\f0 si\hich\af0\dbch\af31505\loch\f0 
stent with a significant UC flare. A CTAP the same month confirmed pancolitis. Previous colonoscopies in 3/2022 showed patchy inflammation in several regions of her colon. No surgeries related to her IBD or EGD/esophagogastroduodenoscopy results were ment
\hich\af0\dbch\af31505\loch\f0 ioned. (ChatGPT-4)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
The 28-year-old female patient has been living with ulcerative colitis (UC) since 2021, characterized by pancolitis and inflammation in the transverse colon, sigmoid, and \hich\af0\dbch\af31505\loch\f0 
rectum. Despite trying Lialda, which provided some improvement, and enemas, which she did not tolerate well, her disease remains severely active. She is currently on infliximab, metronidazole, and prednisone, but continues to experience severe symptoms. R
\hich\af0\dbch\af31505\loch\f0 
ecent endoscopic evaluations, including a flexible sigmoidoscopy in May 2023 showing Mayo 3 colitis, and colonoscopies in 2021 and 2022 demonstrating severe pancolitis and patchy inflammation, respectively, confirm the extent of her disease. There is no r
\hich\af0\dbch\af31505\loch\f0 ec\hich\af0\dbch\af31505\loch\f0 
ord of previous surgeries, and an EGD/esophagogastroduodenoscopy has not been performed. Overall, the patient's UC is currently severely active, with ongoing symptoms and endoscopic evidence of significant inflammation, indicating a need for further adjus
\hich\af0\dbch\af31505\loch\f0 tment to her treatment (Llama-3.3)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 \hich\f0 
Lisa Roberts is a 28-year-old female diagnosed with ulcerative colitis in 2021, currently experiencing severe activity with up to 10 watery bowel movements daily, occasionally bloody, and persistent fever spiking to 101\'b0\loch\f0 
F. Despite treatment with inflixima\hich\af0\dbch\af31505\loch\f0 
b, prednisone (40mg daily), and metronidazole, her symptoms remain uncontrolled. A flexible sigmoidoscopy on 5/5/23 revealed Mayo 3 colitis extending up to 45cm from the anal verge, consistent with a severe flare. She previously started on Lialda with som
\hich\af0\dbch\af31505\loch\f0 e \hich\af0\dbch\af31505\loch\f0 improvement but did not tolerate enemas well. There is no record of previous surgeries related to her IBD. (ChatGPT-4o)
\par }\pard\plain \ltrpar\qj \li-380\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-380\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 2}{
\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Today, I saw Andrea Napoli in the UCLA Center for Inflammatory Bowel Disease for \hich\af0\dbch\af31505\loch\f0 follow up visit.  She is a 26 year old woman presenting for evaluation of diarrhea.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 
First visit in this clinic 8/13/2019 for 2 months of bloody diarrhea (5-7 BMs daily) and abdominal pain. Pain is cramping, not relieved with bowel movements, mostly in the lower quadrants. She had colonoscopy with Dr. Anthony Garfield that revealed mild t
\hich\af0\dbch\af31505\loch\f0 
o moderate left sided colonic inflammation (marked erythema, friability, and erosions). TI was normal. Biopsies showed chronic inflammation, no granulomas or dysplasia. She had MRE with no evidence of small bowel disease, given diagnosis of left-sided ulc
\hich\af0\dbch\af31505\loch\f0 er\hich\af0\dbch\af31505\loch\f0 ative colitis. Started on mesalamine daily and Rowasa. 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (10/21/2019):
\par \hich\af0\dbch\af31505\loch\f0 No further rectal bleeding since starting 5-ASAs
\par \hich\af0\dbch\af31505\loch\f0 Abdominal pain is significantly better as well
\par \hich\af0\dbch\af31505\loch\f0 Still having diarrhea, usually 4-6 BMs daily
\par \hich\af0\dbch\af31505\loch\f0 Having trouble gaining weight
\par \hich\af0\dbch\af31505\loch\f0 Labs from before notable for elevated LFTs, abdominal US with mild hepatic steatosis
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls4\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
26 year old woman with no significant medical history who presented with bloody diarrhea and abdominal pain found to have left sided colitis based on colonoscopy and MRE in (8/2019). Started on oral and topical mesalamines with significant improvement in 
\hich\af0\dbch\af31505\loch\f0 
bleeding and abdominal pain, but continues to have persistent diarrhea. Overall, symptoms are improved but she continues to have persistent diarrhea. Will send a broad workup for other potential etiologies diarrhea that may be contributing, and reassess d
\hich\af0\dbch\af31505\loch\f0 is\hich\af0\dbch\af31505\loch\f0 
ease activity. May need further uptitration of therapies for IBD, including initiation of a biologic, depending on the results, will continue mesalamine for now as she is tolerating well and is showing a good response otherwise on it. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Andrea Napoli, a 26-year-old female with left-sided ulcerative colitis, has been experiencing moderately active symptoms since the onset of her disease, with mild to moderate left-sided colonic inflammation. She has been treated with mesalamine daily and 
\hich\af0\dbch\af31505\loch\f0 
Rowasa, but the exact date of disease onset and any previous surgeries or medications are not defined. Currently, she is experiencing diarrhea and abdominal pain, and her liver function tests are elevated with mild hepatic steatosis. (Llama-2 13B)}{
\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat24\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Andrea Napoli, a 26-year-old woman, was first evaluated on 8/13/2019 for symptoms consistent with left-sided ulcerative colitis. A colonoscopy around this time revealed mild to moderate inflammation on the left side of her colon, with no issues in the ter
\hich\af0\dbch\af31505\loch\f0 
minal ileum. Biopsies confirmed chronic inflammation without granulomas or dysplasia, while an MRE showed no small bowel disease. Currently, she is on daily Mesalamine and Rowasa, experiencing mild symptoms of active IBD, characterized by 4-6 daily bowel 
\hich\af0\dbch\af31505\loch\f0 mo\hich\af0\dbch\af31505\loch\f0 vements, but no rectal bleeding and improved abdominal pain. No surgeries or EGD/esophagogastroduodenoscopy details are available. (ChatGPT 4)}{\rtlch\fcs1 \af0 \ltrch\fcs0 
\f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}}\pard \ltrpar\s30\ql \fi-360\li720\ri0\sa160\sl278\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls4\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Andrea Napoli is a 26-year-old female with left-sided ulcerative colitis, first evaluated on 8/13/2019, presenting with a history of bloody diarrhea (5-7 BMs daily) and abdominal pain. A colonoscopy revealed mild to moderate left-sided colonic inflammatio
\hich\af0\dbch\af31505\loch\f0 
n, with biopsies showing chronic inflammation but no granulomas or dysplasia. She is currently on mesalamine and Rowasa, with no further rectal bleeding reported since starting 5-ASA treatment. Although her abdominal pain has significantly improved, she c
\hich\af0\dbch\af31505\loch\f0 on\hich\af0\dbch\af31505\loch\f0 
tinues to experience moderate activity of her disease, with 4-6 BMs daily and difficulties gaining weight. The date of disease onset is not defined, and there are no previous surgeries recorded. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}}\pard \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls4\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Andrea Napoli, a 26-year-old female, has left-sided ulcerative colitis, with symptoms first presenting approximately 2 months prior to her initial visit on 8/13/2019. She is currently being managed with mesalamine and Rowasa (5-ASAs), with no prior IBD me
\hich\af0\dbch\af31505\loch\f0 
dications or surgeries reported. Her disease is currently moderately active, characterized by 4-6 daily bowel movements with diarrhea, although rectal bleeding has resolved and abdominal pain has improved significantly. A colonoscopy, performed as part of
\hich\af0\dbch\af31505\loch\f0  h\hich\af0\dbch\af31505\loch\f0 
er initial diagnosis, revealed mild to moderate left-sided colonic inflammation, while an MRE showed no evidence of small bowel disease; no recent flexible sigmoidoscopy or EGD/esophagogastroduodenoscopy results are available. Overall, her condition is be
\hich\af0\dbch\af31505\loch\f0 ing monitored and managed with her current medication regimen.\~\~(Llama-3.3)
\par }\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 3}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Layla Fakhoury is a 18 year old woman with history of ileal Crohn\hich\f0 \rquote \loch\f0 s disease.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 IBD History:
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}}\pard\plain \ltrpar
\s30\qj \fi-360\li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls3\adjustright\rin-20\lin-20\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 \hich\f0 Has had chronic digestive issues \'93
\loch\f0 \hich\f0 her whole life\'94\loch\f0  since she was 8
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}\hich\af0\dbch\af31505\loch\f0 Has been \hich\af0\dbch\af31505\loch\f0 
having issues with chronic constipation, hemorrhoids, rectal pain since 2015: Follows with Dr. Sarah Park at Children\hich\f0 \rquote \loch\f0 
s Hospital of Everytown. Has tried psyllium, miralax, linzess, and topical medications with varying success. Usually has 1 BM every 2-3 d\hich\af0\dbch\af31505\loch\f0 ays at baseline.
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}\hich\af0\dbch\af31505\loch\f0 
2017: Severe rectal pain for 3 months, saw Dr. Kim on 8/30/2017 perianal exam notable for two anal fissures. Prescribed psyllium, miralax, and topical diltiazem.
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}\hich\af0\dbch\af31505\loch\f0 Fecal calprotectin 10/6/2017 elevated at 185
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}\hich\af0\dbch\af31505\loch\f0 
EGD and colonoscopy 11/13/2017 with aphthous ulcers in the terminal ileum, perianal inflammation and fissures, no obvious fistula seen, concerning for Crohn disease. EGD with mild gastritis. Biopsies negative for H pylori and dysplasia.
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}\hich\af0\dbch\af31505\loch\f0 MRE 12/05/2017 with a 4-6cm of inflammation in the terminal ileum.
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \f45\kerning2\insrsid15621951\charrsid14615927 \hich\af45\dbch\af31505\loch\f45 -\tab}\hich\af0\dbch\af31505\loch\f0 Referred by Dr. Park to discuss new diagnosis, treatment options
\par }\pard\plain \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (12/21/2017)
\par \hich\af0\dbch\af31505\loch\f0 At baseline, has 1 BM every 3-5 days.
\par \hich\af0\dbch\af31505\loch\f0 Rectal pain has improved, taking topical diltiazem
\par \hich\af0\dbch\af31505\loch\f0 Occasionally still has severe pain, occasional BRB, usually associated with constipation, but not always.
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls5\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
19 year old woman with chronic constipation, hemorrhoids, anal fissures and a recent diagnosis of ileal Crohn\hich\f0 \rquote \loch\f0 
s disease with perianal involvement. Overall, she is not having significant symptoms, but she has multiple fissures which is concerning for early\hich\af0\dbch\af31505\loch\f0 
 perianal involvement.  We discussed the available options including continuing with surveillance vs initiating therapy. We discussed that it can be difficult to treat perianal disease, and that early initiation of biologic therapy may prevent complicatio
\hich\af0\dbch\af31505\loch\f0 ns\hich\af0\dbch\af31505\loch\f0 
 that can be challenging to treat. Given possible perianal involvement, recommended starting a TNF-inhibitor. She and her mother had several excellent questions about the safety profile of anti-TNF therapy which were answered, we discussed that there is a
\hich\af0\dbch\af31505\loch\f0 
 signal for higher risk from lymphoma and infections, but the low overall absolute risk. We discussed infliximab and adalimumab. Both were concerned with the logistical difficulties of infusion therapy with infliximab, and they wanted to try adalimumab. (
\hich\af0\dbch\af31505\loch\f0 Hu\hich\af0\dbch\af31505\loch\f0 man)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Layla Fakhoury, an 18-year-old female with a history of ileal Crohn's disease, has been experiencing chronic digestive issues and rectal pain for several years. She has had no previous surgeries and is currently taking psyllium, miralax, linzess, and topi
\hich\af0\dbch\af31505\loch\f0 
cal diltiazem to manage her symptoms. While her current bowel movement frequency is 1 BM every 3-5 days, she still experiences occasional severe pain and rectal bleeding. A recent flexible sigmoidoscopy and EGD/esophagogastroduodenoscopy revealed mild gas
\hich\af0\dbch\af31505\loch\f0 tr\hich\af0\dbch\af31505\loch\f0 
itis and negative biopsies for H pylori and dysplasia, and her IBD is currently moderately active. Despite some improvement with topical diltiazem, Layla continues to experience occasional severe rectal pain and BRB. (Llama-2 13B)}{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat24\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 Layla Fakhoury, an 18-year-old woman, has been experiencing chronic digestive issues consistent with ileal Crohn\hich\f0 \rquote \loch\f0 
s disease since she was 8. She is currently on topical diltiazem for management. Previously, she has tried IBD medications including psyllium,\hich\af0\dbch\af31505\loch\f0 
 miralax, linzess, and other unspecified topical treatments with varying degrees of success. Her IBD presently manifests as mild symptoms, characterized by improved rectal pain but intermittent episodes of severe pain and occasional bright red blood, ofte
\hich\af0\dbch\af31505\loch\f0 n \hich\af0\dbch\af31505\loch\f0 
associated with constipation. A colonoscopy on 11/13/2017 revealed aphthous ulcers in the terminal ileum, perianal inflammation, and fissures indicative of Crohn's disease, while an EGD conducted on the same day showed mild gastritis with biopsies negativ
\hich\af0\dbch\af31505\loch\f0 e for H pylori and dysplasia. She has not undergone any surgeries related to her condition. (ChatGPT-4)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
The 18-year-old female patient has ileal Crohn's disease, with symptoms dating back to age 8, although the exact \hich\af0\dbch\af31505\loch\f0 
date of disease onset is unclear. She is currently managed with psyllium, miralax, linzess, and topical diltiazem, having previously tried these medications with varying success. Her disease is currently moderately active, with improved rectal pain but on
\hich\af0\dbch\af31505\loch\f0 
going occasional severe pain and constipation. She has no defined history of previous surgeries. Recent diagnostic tests include an EGD on 11/13/2017 showing mild gastritis, and a colonoscopy on the same date revealing aphthous ulcers in the terminal ileu
\hich\af0\dbch\af31505\loch\f0 m,\hich\af0\dbch\af31505\loch\f0 
 perianal inflammation, and fissures. An MRE on 12/05/2017 confirmed 4-6cm of inflammation in the terminal ileum, while a flexible sigmoidoscopy has not been performed. Overall, her disease remains active, despite some improvement in symptoms, and ongoing
\hich\af0\dbch\af31505\loch\f0  management with her current medication regimen is necessary.\~\~(Llama-3.3)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 Layla Fakhoury is an 18-year-old woman with ileal Crohn\hich\f0 \rquote 
\loch\f0 s disease, experiencing chronic digestive issues since age 8. She has a history of rectal pain and constipation, managed with topical diltiazem and other medications, leading to variable success. Her\hich\af0\dbch\af31505\loch\f0 
 most recent EGD and colonoscopy on 11/13/2017 revealed aphthous ulcers in the terminal ileum and perianal inflammation, indicating moderately active disease. Currently, she has 1 bowel movement every 3-5 days, with occasional severe pain and bright red b
\hich\af0\dbch\af31505\loch\f0 lo\hich\af0\dbch\af31505\loch\f0 od per rectum, typically associated with constipation. The date of disease onset is not defined, and no previous surgeries have been noted. (ChatGPT-4o)
\par }\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \column }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 Case 4}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}
{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Today, I saw Jane Smith in the UCLA Center for Inflammatory Bowel Disease in consultation regarding biologic therapy for UC post-colectomy.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Jane Smith is a 25-year-old woman with a history of colectomy due to severe UC, currently on biologic therapy.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 11/2015 \hich\f0 \endash \loch\f0  Admitted to Palmsdale Presbyterian Hospital with severe UC flare with hematochezia. Did not respond to Remicade of IV steroids, underwent colectomy with colostomy
\par \hich\af0\dbch\af31505\loch\f0 12/2016 \hich\f0 \endash \loch\f0  Follow-up in GI clinic after surgery, doing well.
\par \hich\af0\dbch\af31505\loch\f0 6/2016 \hich\f0 \endash \loch\f0  Underwent colostomy takedown and creation of IPAA
\par \hich\af0\dbch\af31505\loch\f0 9/2017 \hich\f0 \endash \loch\f0  Doing well, 6 BM daily, new baseline since IPAA. 
\par \hich\af0\dbch\af31505\loch\f0 2/2018 \hich\f0 \endash \loch\f0  Episode of pouchitis responded to cipro
\par \hich\af0\dbch\af31505\loch\f0 5/2019 \hich\f0 \endash \loch\f0  Had an episode of pouchitis, sigmoidoscopy showed inflammation of the pouch, no inflammation seen beyond the pouch. Responded to cipro.
\par \hich\af0\dbch\af31505\loch\f0 2020 \hich\f0 \endash \loch\f0  Doing well at last visit
\par \hich\af0\dbch\af31505\loch\f0 2020-2023 \hich\f0 \endash \loch\f0  Lost in insurance, lost to follow up
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (4/5/23):
\par \hich\af0\dbch\af31505\loch\f0 Having 6 BM daily
\par \hich\af0\dbch\af31505\loch\f0 No blood or urgency
\par \hich\af0\dbch\af31505\loch\f0 Not on any IBD medications
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2015
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls6\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Jane Smith is a 25-year-old woman with ulcerative colitis (diagnosed 2015) who is post-colectomy and IPAA, not on biologic \hich\af0\dbch\af31505\loch\f0 
therapy. She presented with a severe flare in 2015 that was not responsive to Remicade and underwent colectomy upon initial presentation. She has been doing well since her operation. We discussed HCM at today\hich\f0 \rquote \loch\f0 s visit. (Human)

\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\dbch\af31506\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31506\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
Jane Smith, a 25-year-old female, has been diagnosed with ulcerative colitis (UC) since 2015. She has undergone colectomy with colostomy, takedown of colostomy, and creation of an ileal pouch-anal anastomosis (IPAA). Currently, she is not taking any medic
ations for her IBD. Previously, she had failed Remicade and IV steroids. The current activity of her IBD is not specified. There is no information provided on the date and results of her most recent flexible sigmoidoscopy, EGD/esophagogastroduodenoscopy, 
and colonoscopies. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\dbch\af31506\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31506\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
Jane Smith, a 25-year-old woman, has been diagnosed with Ulcerative Colitis (UC) since 2015. In her disease journey, she underwent a colectomy with colostomy due to a severe UC episode and later had a colostomy takedown, followed by the creation of an IPA
A. Although she did not respond to treatments like Remicade and IV steroids during her severe flare, she successfully responded to Cipro for episodes of pouchitis in 2018 and 2019. A sigmoidoscopy in 5/2019 revealed inflammation confined to the pouch. Cur
rently, she is not on any IBD medications, and her disease is well-controlled, evident from her 6 daily bowel movements without any blood or urgency. (ChatGPT-4)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
The 25-year-old female patient has a history of Ulcerative Colitis (UC) that onset in 2015, and has undergone significant surgical management, including colectomy with colostomy in 11/2015 and colostomy takedown with creation of IPAA in 6/2016. She has pr
\hich\af0\dbch\af31505\loch\f0 
eviously been treated with Remicade and IV steroids, but failed to respond to these medications, leading to her colectomy. Additionally, she has been treated with Cipro for pouchitis, which was effective. Currently, she is not on any IBD medications and h
\hich\af0\dbch\af31505\loch\f0 er\hich\af0\dbch\af31505\loch\f0 
 disease is well-controlled, with 6 bowel movements daily and no blood or urgency. Her most recent sigmoidoscopy in 5/2019 showed inflammation of the pouch, but no inflammation beyond it, while EGD/esophagogastroduodenoscopy and colonoscopy results are no
\hich\af0\dbch\af31505\loch\f0 t defined, likely due to her previous colectomy. (Llama-3.3)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}}\pard \ltrpar\s30\ql \fi-360\li720\ri0\sa160\sl278\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls6\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Jane Smith is a 25-year-old woman with a history of ulcerative colitis (UC) diagnosed in 2015, who underwent colectomy with colostomy due to severe flare that did not respond to Remicade or IV steroids. She later had a colostomy takedown and created an il
\hich\af0\dbch\af31505\loch\f0 
eal pouch-anal anastomosis (IPAA). Currently, she is not on any IBD medications and reports having 6 bowel movements daily, with no blood or urgency, indicating her UC is well-controlled. The most recent flexible sigmoidoscopy showed pouch inflammation bu
\hich\af0\dbch\af31505\loch\f0 t \hich\af0\dbch\af31505\loch\f0 no additional details were provided. (ChatGPT-4o)
\par }\pard\plain \ltrpar\ql \li360\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin360\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 5}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}
{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Today, I saw Jonathan Stevens in the UCLA Center for Inflammatory Bowel Disease for a consultation regarding UC with pouchitis post J-pouch surgery.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Jonathan Stevens is a 34-year-old man with a history of ulcerative pancolitis, for which he underwent a total proctocolectomy and IPAA.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 2008 \hich\f0 \endash \loch\f0 Diagnosed with UC \hich\af0\dbch\af31505\loch\f0 
after persistent bloody diarrhea and abdominal pain with CT imaging showing pancolitis. Sigmoidoscopy confirmed UC with Mayo 3 colitis throughout the extent of exam, 40cm from the anal verge. He underwent numerous treatments including IV steroids, inflixi
\hich\af0\dbch\af31505\loch\f0 
mab, methotrexate, azathioprine, adalimumab, and ustekinumab without significant improvement. Essentially steroid dependent for a year. Ultimately underwent elective surgery after nutritional optimization. This was in Valley Ridge Memorial. Records are no
\hich\af0\dbch\af31505\loch\f0 t \hich\af0\dbch\af31505\loch\f0 available.
\par \hich\af0\dbch\af31505\loch\f0 2008-2009 \hich\f0 \endash \loch\f0  Underwent elective total proctocolectomy and had a J-pouch constructed. Post-operative period was uneventful, and he initially did well.
\par \hich\af0\dbch\af31505\loch\f0 2010 \hich\f0 \endash \loch\f0  Had hospitalization for SBO s/p ex-lap with LOA
\par \hich\af0\dbch\af31505\loch\f0 2012 \hich\f0 \endash \loch\f0  Had another hospitalization for SBO, managed conservatively
\par \hich\af0\dbch\af31505\loch\f0 2015- Had an episode of pouchitis. Recalls getting antibiotics and he felt better
\par \hich\af0\dbch\af31505\loch\f0 2015-2022 \hich\f0 \endash \loch\f0  Overall did well, until recently.
\par \hich\af0\dbch\af31505\loch\f0 11/2022 \hich\f0 \endash \loch\f0  Began experiencing increased frequency of bowel movements, urgency, and occasional blood in stools, suggestive of pouchitis. Received cipro with improvement. 
\par \hich\af0\dbch\af31505\loch\f0 3/12/23 \hich\f0 \endash \loch\f0 
 Seen in Union City Hospital for diarrhea, hematochezia, C diff PCR negative, CTAP showed inflammation of the J-pouch concerning for pouchitis. Patient was discharged with 1-week follow up in GI clinic.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (4/5/23):
\par \hich\af0\dbch\af31505\loch\f0 Reports 10-12 BMs daily, watery consistency with intermittent blood streaks. The patient denies any nocturnal awakenings or systemic symptoms like fever or weight loss. 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2008
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls7\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Jonathan Stevens, a 34-year-old man, presents with recurrent symptoms suggestive of pouchitis following a J-pouch construction due to severe UC. He is reporting frequent, watery bowel movements with intermittent blood. Given the persistent symptoms and pr
\hich\af0\dbch\af31505\loch\f0 ior history, there's a high suspicion of pouchitis. Discussion ensued about the potential need for antibiotic therapy and pouchoscopy. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Mr. Stevens, a 34-year-old male, has been diagnosed with ulcerative colitis (UC) since 2008, with a history of total proctocolectomy and IPAA (J-pouch) surgery. He has been experiencing moderately active pouchitis with 10-12 bowel movements per day, water
\hich\af0\dbch\af31505\loch\f0 
y in consistency with intermittent blood streaks. He is currently taking cipro for his pouchitis, and has previously tried IV steroids, infliximab, methotrexate, azathioprine, adalimumab, and ustekinumab without significant improvement. There is no mentio
\hich\af0\dbch\af31505\loch\f0 n \hich\af0\dbch\af31505\loch\f0 
of nocturnal awakenings or systemic symptoms such as fever or weight loss. His disease onset was in 2008, and he has had several procedures in the past, including flexible sigmoidoscopy, EGD/esophagogastroduodenoscopy, and colonoscopies, although the date
\hich\af0\dbch\af31505\loch\f0 s and results of these procedures are not specified. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat24\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Jonathan Stevens, diagnosed with ulcerative pancolitis in 2008, underwent a total proctocolectomy, IPAA (J-pouch) construction, and a surgical intervention for small bowel obstruction, which required exploratory laparotomy with lysis of adhesions. Despite
\hich\af0\dbch\af31505\loch\f0 
 various IBD medications, including IV steroids, infliximab, methotrexate, azathioprine, adalimumab, and ustekinumab, there was no significant relief, although ciprofloxacin administered in 11/2022 did ameliorate his pouchitis. Currently, he presents with
\hich\af0\dbch\af31505\loch\f0  m\hich\af0\dbch\af31505\loch\f0 
oderate IBD activity, experiencing 10-12 daily bowel movements of watery consistency and intermittent blood streaks. A sigmoidoscopy in 2008 confirmed UC with Mayo 3 colitis up to 40cm from the anal verge, and a CTAP in 3/12/23 indicated inflammation of t
\hich\af0\dbch\af31505\loch\f0 he J-pouch, suggesting pouchitis. (ChatGPT 4)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
Jonathan Stevens is a 34-year-old male with a history of ulcerative pancolitis, diagnosed in 2008, for which he underwent total proctocolectomy and ileal pouch-anal anastomosis (IPAA). He has been on multiple medications, including IV steroids, infliximab
\hich\af0\dbch\af31505\loch\f0 
, methotrexate, azathioprine, adalimumab, and ustekinumab, but did not achieve significant improvement and was steroid-dependent for a year. Currently, he is experiencing moderately active disease, reporting 10-12 watery bowel movements daily with intermi
\hich\af0\dbch\af31505\loch\f0 tt\hich\af0\dbch\af31505\loch\f0 
ent blood streaks. His most recent evaluation indicated inflammation of the J-pouch, but specific endoscopic findings are not defined. He has been treated with ciprofloxacin for pouchitis since November 2022. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 
The 34-year-old male patient has a 15-year history of ulcerative pancolitis, which onset in 2008, and has undergone significant surgical interventions, including total proctocolectomy, IPAA with J-pouch construction, and exploratory laparotomy for small b
\hich\af0\dbch\af31505\loch\f0 
owel obstruction. Despite trying multiple medications, including IV steroids, infliximab, methotrexate, azathioprine, adalimumab, and ustekinumab, which all failed to achieve significant improvement, the patient's current IBD medication regimen is unclear
\hich\af0\dbch\af31505\loch\f0 . \hich\af0\dbch\af31505\loch\f0 
The patient's disease is currently severely active, characterized by 10-12 daily bowel movements with watery consistency and intermittent blood streaks. Recent diagnostic tests include a CTAP on 3/12/23 showing inflammation of the J-pouch concerning for p
\hich\af0\dbch\af31505\loch\f0 ouchitis, and a negative C diff PCR on the same date, while a sigmoidoscopy in 2008 confirmed UC with Mayo 3 colitis. (Llama-3.3)
\par }\pard\plain \ltrpar\ql \li360\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin360\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par }\pard \ltrpar\qj \li0\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 6}{\rtlch\fcs1 
\af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}
{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Mr. John Miller is a 62-year-old man with a past medical history of hypertension, hyperlipidemia, and osteoarthritis who has a history of stricturing ileocolonic Crohn\hich\f0 \rquote \loch\f0 
s disease (diagnosed 2016) with symptom progression despite biologic therapy.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 IBD History:
\par \hich\af0\dbch\af31505\loch\f0 2016 \hich\f0 \endash \loch\f0 
 Presented with chronic, intermittent abdominal pain, bloating, and a significant weight loss of about 20 pounds over 6 months. 2/2016 ED visit for an acute flare of abdominal pain. CTAP showed thickening and inflammation of a 15cm segment in the te
\hich\af0\dbch\af31505\loch\f0 
rminal ileum. MRE 3/2016 confirmed these findings. Treated with oral steroids with temporary improvement. Colonoscopy notable for ulcerations and narrowed lumen in TI. Biopsies showed chronic inflammation consistent with Crohn\hich\f0 \rquote \loch\f0 
s disease. No upper GI invol\hich\af0\dbch\af31505\loch\f0 ve\hich\af0\dbch\af31505\loch\f0 ment seen on EGD.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 3/2016 \hich\f0 \endash \loch\f0  Started on Remicade with initial improvement.
\par \hich\af0\dbch\af31505\loch\f0 6/2016 \hich\f0 \endash \loch\f0  Remicade infusion, patient reported occasional abdominal discomfort.
\par \hich\af0\dbch\af31505\loch\f0 10/2016 \hich\f0 \endash \loch\f0  Continuing to have diarrhea, abdominal pain. Humira therapy initiated.
\par \hich\af0\dbch\af31505\loch\f0 1/2017 \hich\f0 \endash \loch\f0  Symptomatic relief with Humira.
\par \hich\af0\dbch\af31505\loch\f0 9/2017 \hich\f0 \endash \loch\f0  MRE showed persistent inflammation, Humira dose increased.
\par \hich\af0\dbch\af31505\loch\f0 12/2017 \hich\f0 \endash \loch\f0  Clinical remission Humira dose.
\par \hich\af0\dbch\af31505\loch\f0 6/2018 \hich\f0 \endash \loch\f0  Stricture symptoms began with intermittent obstructions, managed conservatively.
\par \hich\af0\dbch\af31505\loch\f0 12/2018 \hich\f0 \endash \loch\f0  Elective hospital admission for total parenteral nutrition due to obstructive symptoms.
\par \hich\af0\dbch\af31505\loch\f0 3/2019 \hich\f0 \endash \loch\f0  Discussed surgical options.
\par \hich\af0\dbch\af31505\loch\f0 6/2019 \hich\f0 \endash \loch\f0  Decision to try Cimzia.
\par \hich\af0\dbch\af31505\loch\f0 8/2019 \hich\f0 \endash \loch\f0  Minimal symptomatic relief with Cimzia.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today 12/2022
\par \hich\af0\dbch\af31505\loch\f0 Continues to have 3-4 episodes of partial \hich\af0\dbch\af31505\loch\f0 obstructions monthly.
\par \hich\af0\dbch\af31505\loch\f0 High stress due to symptoms affecting his quality of life.
\par \hich\af0\dbch\af31505\loch\f0 Experiencing abdominal cramps regularly.
\par \hich\af0\dbch\af31505\loch\f0 He reports no change in appetite but has unintentional weight loss of 5 lbs in the last month.
\par \hich\af0\dbch\af31505\loch\f0 Recent CTE showed long segmental stricture, referral to surgery required.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2016
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\qj \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls8\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Mr. Miller, a 62-year-old man with a history of ileocolonic Crohn\hich\f0 \rquote \loch\f0 
s disease (diagnosed 2016), has a chronic, symptomatic stricture despite maintenance therapy on Certolizumab pegol. The stricture has led to partial obstructions and increased morbidity. Re\hich\af0\dbch\af31505\loch\f0 
ferral to surgery for evaluation and likely surgical intervention is needed. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}\pard \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls8\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Mr. John Miller, a 62-year-old male, has been diagnosed with stricturing ileocolonic Crohn's disease since 2016. He has experienced persistent symptoms despite treatment with Remicade, Humira, and Cimzia. There is no mention of previous surgeries or the r
\hich\af0\dbch\af31505\loch\f0 eason for failure of previous medications. The current activity of his IBD is not specified, and there is no information on the date and results of recent endoscopic procedures. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 
\f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}\pard \ltrpar
\s30\qj \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls8\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Mr. John Miller, a 62-year-old man, was diagnosed with stricturing ileocolonic Crohn\hich\f0 \rquote \loch\f0 
s disease in 2016. Although he hasn't undergone any surgeries for the condition, his medical regimen has included oral steroids (with temporary improvement), Remicade (wh\hich\af0\dbch\af31505\loch\f0 
ich initially helped but later caused abdominal discomfort), Humira (which achieved symptomatic relief and later reached clinical remission with an increased dose), and Cimzia (providing minimal relief). Currently, his Crohn's disease is moderately active
\hich\af0\dbch\af31505\loch\f0 , \hich\af0\dbch\af31505\loch\f0 
as evidenced by frequent partial obstructions, abdominal cramps, and recent unintentional weight loss. His 2016 colonoscopy revealed ulcerations and a narrowed lumen in the terminal ileum with biopsies consistent with Crohn's disease, while an EGD from th
\hich\af0\dbch\af31505\loch\f0 e same year showed no upper GI involvement. A recent CTE in December 2022 identified a long segmental stricture. (ChatGPT-4)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
The 62-year-old male patient has a 6-year history of ileocolonic Crohn's disease, which onset in 2016. He has been treated with various medications, including Remicade, which failed due to symptom progression, and Humira, which initially provided relief b
\hich\af0\dbch\af31505\loch\f0 
ut later showed persistent inflammation. Currently, he is on Cimzia, but reports minimal symptomatic relief. The patient's disease is severely active, characterized by 3-4 episodes of partial obstructions monthly, abdominal cramps, and unintentional weigh
\hich\af0\dbch\af31505\loch\f0 t \hich\af0\dbch\af31505\loch\f0 
loss. His medical history does not indicate any previous surgeries. Recent imaging studies, including a CTE, have shown a long segmental stricture, prompting a referral for surgery. Previous diagnostic tests, such as a 2016 colonoscopy, EGD, and MRE, have
\hich\af0\dbch\af31505\loch\f0  consistently demonstrated chronic inflammation and ulcerations consistent with Crohn's disease, highlighting the aggressive nature of his condition. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 Mr. John Miller is a 62-year-old male with stricturing ileocolonic Crohn
\hich\f0 \rquote \loch\f0 s disease diagnosed in 2016. He has a history of multiple medication trials, including Remicade, Humira, and Cimzia, with minimal improvement and persistent symptoms such as abdomina\hich\af0\dbch\af31505\loch\f0 
l cramps and partial obstructions occurring 3-4 times monthly. He has experienced unintentional weight loss of 5 lbs in the last month. His most recent imaging (CTE) revealed a long segmental stricture, prompting a referral for surgical evaluation. The pa
\hich\af0\dbch\af31505\loch\f0 ti\hich\af0\dbch\af31505\loch\f0 ent's current IBD activity is moderately active, with no current medications documented. (Llama-3.3)
\par }\pard \ltrpar\s30\qj \li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard\plain \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 7
\par }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the \hich\af0\dbch\af31505\loch\f0 
following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Jane Doe is a 32-year-old woman who is currently 20 weeks pregnant. She has a past medical history of hypothyroidism, allergic rhinitis, and Crohn's disease which has been under control with the use of adalimumab.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 IBD History:
\par \hich\af0\dbch\af31505\loch\f0 2016 \hich\f0 \endash \loch\f0  presented with severe abdominal pain, diarrhea, and weight loss. Colonoscopy revealed ulcerations in the terminal ileum with biopsies confirming Crohn's disease.
\par \hich\af0\dbch\af31505\loch\f0 2017 \hich\f0 \endash \loch\f0  initiated on adalimumab therapy. Achieved clinical remission within 6 months. 
\par \hich\af0\dbch\af31505\loch\f0 10/2017 \hich\f0 \endash \loch\f0  Colonoscopy with endoscopic healing
\par \hich\af0\dbch\af31505\loch\f0 2019 \hich\f0 \endash \loch\f0  Continued on maintenance therapy with adalimumab. Colonoscopy showed mucosal healing.
\par \hich\af0\dbch\af31505\loch\f0 2021 \hich\f0 \endash \loch\f0  learned of her pregnancy, voiced concerns about continuing medication. Counseled about the safety of adalimumab during pregnancy and decided to continue therapy.
\par \hich\af0\dbch\af31505\loch\f0 2022 \hich\f0 \endash \loch\f0  no disease flare-ups. Adhering to treatment. Routine check-ups have been satisfactory. The pregnancy is progressing without complications.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today 2/2022:
\par \hich\af0\dbch\af31505\loch\f0 
Ms. Doe expresses concerns about potential implications of her Crohn's on the pregnancy. She reports mild nausea but attributes this to pregnancy. She denies diarrhea, abdominal pain, or any alarming symptoms. She wishes to discuss the safety of continuin
\hich\af0\dbch\af31505\loch\f0 g Adalimumab during the remainder of her pregnancy.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2016
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\qj \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls9\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
This is a 32 year-old woman with past medical history of Hypothyroidism, Allergic rhinitis, now  in remission on Humira. Overall, her condition is now stable. She denies diarrhea, abdominal pain, or any alarming symptoms. She is currently continuing Humir
\hich\af0\dbch\af31505\loch\f0 a; she is currently doing well. We discussed the the safety of continuing Adalimumab during the remainder of her pregnancy. She is agreeable to continuing Humira at today\hich\f0 \rquote \loch\f0 
s visit. We discussed the risk of developing antibodies and losing response to Humri\hich\af0\dbch\af31505\loch\f0 a \hich\af0\dbch\af31505\loch\f0 in the future and how we will need close monitoring. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}\pard \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls9\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Ms. Doe, a 32-year-old female, has been diagnosed with Crohn's disease since 2016. She has had no previous surgeries and is currently on adalimumab, with no history of previous medication failures. Her IBD is well-controlled, with mucosal healing observed
\hich\af0\dbch\af31505\loch\f0 
 in her most recent colonoscopy in 2019. She experiences mild symptoms and has had no recent flexible sigmoidoscopy, EGD/esophagogastroduodenoscopy, or colonoscopies. Overall, her Crohn's disease is well-controlled and she is adhering to her current treat
\hich\af0\dbch\af31505\loch\f0 me\hich\af0\dbch\af31505\loch\f0 nt plan. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat24\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
Jane Doe, a 32-year-old woman, was diagnosed with Crohn's disease in 2016, evidenced by ulcerations in the terminal ileum. Since diagnosis, she has been managed with Adalimumab, achieving clinical remission. Her IBD is currently well-controlled, with no r
\hich\af0\dbch\af31505\loch\f0 
ecent flare-ups. Notably, colonoscopies in 2016 confirmed her diagnosis, showed endoscopic healing in 10/2017, and evidenced mucosal healing in 2019. No surgeries related to her IBD or other IBD medications have been reported. (ChatGPT-4)}{\rtlch\fcs1 
\af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
Jane Doe is a 32-year-old woman with a history of Crohn's disease affecting the terminal ileum, diagnosed in 2016. She has been on adalimumab since 2017, achieving clinical remission with no reported failures or disease flare-ups. The most recent colonosc
\hich\af0\dbch\af31505\loch\f0 
opy in 2019 showed mucosal healing, and she has been maintaining her treatment during her current pregnancy, which is progressing without complications. Her Crohn's disease is currently well-controlled, with no symptoms of diarrhea or abdominal pain repor
\hich\af0\dbch\af31505\loch\f0 te\hich\af0\dbch\af31505\loch\f0 d as of February 2022. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 
The 32-year-old female patient has a 6-year history of Crohn's disease, specifically with ulcerations in the terminal ileum, since its onset in 2016. She is currently well-controlled on adalimumab, with no reported previous surgeries or 
\hich\af0\dbch\af31505\loch\f0 
failed IBD medications. Her disease course has been marked by significant improvement, with colonoscopies in 2017 and 2019 showing endoscopic healing and mucosal healing, respectively. Although the results of her most recent colonoscopy in 2022 are not sp
\hich\af0\dbch\af31505\loch\f0 
ecified, routine check-ups have been satisfactory, and she currently reports no symptoms of active disease, aside from mild nausea attributed to her pregnancy. Notably, there is no record of her having undergone flexible sigmoidoscopy or EGD/esophagogastr
\hich\af0\dbch\af31505\loch\f0 od\hich\af0\dbch\af31505\loch\f0 
uodenoscopy, and her previous surgical history is unclear. Overall, her Crohn's disease remains well-controlled on adalimumab, with a favorable disease course and no recent evidence of active inflammation. (Llama-3.3)
\par }\pard \ltrpar\s30\ql \li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard\plain \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 
\f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 8}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}
{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 John Smith is a 38-year-old man with a history of colectomy due to severe UC, currently on biologic therapy.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 11/2015 \hich\f0 \endash \loch\f0 
 Admitted to Southern California Memorial Hospital with severe UC flare with diarrhea, hematochezia, fevers, and abdominal pain. Did not respond to Remicade of IV steroids, underwent colectomy with colostomy
\par \hich\af0\dbch\af31505\loch\f0 12/2016 \hich\f0 \endash \loch\f0  Follow-up in GI clinic after surgery, doing well. Started Entyvio post-operatively on 12/28 
\par \hich\af0\dbch\af31505\loch\f0 6/2017 \hich\f0 \endash \loch\f0  Underwent colostomy takedown and creation of IPAA
\par \hich\af0\dbch\af31505\loch\f0 9/2017 \hich\f0 \endash \loch\f0  Doing well, 6 BM daily, new baseline since IPAA. 
\par \hich\af0\dbch\af31505\loch\f0 2/2018 \hich\f0 \endash \loch\f0  Episode of pouchitis responded to cipro
\par \hich\af0\dbch\af31505\loch\f0 5/2018 \hich\f0 \endash \loch\f0  Had an episode of pouchitis, cipro/flagyl x 14 days with improvement. 
\par \hich\af0\dbch\af31505\loch\f0 12/2018 \hich\f0 \endash \loch\f0  GI clinic visit, noting diarrhea, 25-50% of BMs bloody. 
\par \hich\af0\dbch\af31505\loch\f0 1/2019 \hich\f0 \endash \loch\f0 
 Sigmoidoscopy with diffuse inflammation, granularity, erythema throughout the pouch, including the efferent limb, with sparing of the pre-pouch ileum. Started augmentin and VSL3 with some improvement in symptoms
\par \hich\af0\dbch\af31505\loch\f0 5/2019 \hich\f0 \endash \loch\f0  Doing better than last visit, but still having more loose stools, occasional blood in stools. Rifaximin prescribed.
\par \hich\af0\dbch\af31505\loch\f0 10/2019 \hich\f0 \endash \loch\f0 
 Sigmoidoscopy with persistent, diffuse inflammation in pouch, extending into the pre-pouch ileum 50cm from the anal verge. Mesalamine/budesonide enemas prescribed. Discussed possible pouchitis vs. Crohn\hich\f0 \rquote \loch\f0 s of the pouch
\par \hich\af0\dbch\af31505\loch\f0 
2/2020 -  Sigmoidoscopy could not be completed due to rectal stricture 5cm from anal verge; persistent diffuse inflammation seen beyond the stricture. MRE abdomen/pelvis notable for pouchitis and two possible ileal strictures.
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Currently 3/2/2020}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Still having 6-8 BMs daily, rare urgency
\par \hich\af0\dbch\af31505\loch\f0 Occasional blood
\par \hich\af0\dbch\af31505\loch\f0 No abdominal pain, \hich\af0\dbch\af31505\loch\f0 fevers, nocturnal symptoms
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2015
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls10\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
38 year old man status post-colectomy and IPAA due to previous diagnosis of severe UC (diagnosed in 2015) not on biologic therapy with recurrent pouchitis, with recent sigmoidoscopy and MRE concerning for Crohn\hich\f0 \rquote \loch\f0 
s disease of the pouch with ongoing inflamma\hich\af0\dbch\af31505\loch\f0 
tion of the pouch and new rectal and ileal stricture. Will need to discuss case at next IBD conference with radiology and surgery and review imaging. If strictures are amenable to endoscopic therapy, which they appear to be at this time, will refer to adv
\hich\af0\dbch\af31505\loch\f0 an\hich\af0\dbch\af31505\loch\f0 
ced GI service. He is symptomatic with diarrhea and occasional bleeding, although symptoms are overall manageable. We discussed initiating treatment with a biologic to prevent further complications. Given the findings concerning for structuring Crohn dise
\hich\af0\dbch\af31505\loch\f0 
ase we will plan to initiate Remicade. We discussed the risks of infection, malignancy including lymphoma, and need for HCM including being up to date with vaccinations and annual melanoma screening. We will need to check labs prior to starting. (Human)

\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
John Smith, a 38-year-old male, was diagnosed with severe ulcerative colitis (UC) in 2015, which led to a colectomy with colostomy. He has been managed with various medications, including Entyvio, augmentin, VSL3, rifaximin, and mesalamine/budesonide enem
\hich\af0\dbch\af31505\loch\f0 
as. His most recent flexible sigmoidoscopies in January 2019 and May 2019 showed persistent, diffuse inflammation in the pouch, with sparing of the pre-pouch ileum. The patient experienced occasional blood in stools, rare urgency, and no abdominal pain or
\hich\af0\dbch\af31505\loch\f0  f\hich\af0\dbch\af31505\loch\f0 
evers. Despite treatment, the patient has experienced recurrent pouchitis and rectal strictures, which have been managed with mesalamine/budesonide enemas and rifaximin. The patient's current activity of IBD is not well controlled, and further evaluation 
\hich\af0\dbch\af31505\loch\f0 is needed to optimize his treatment. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}\hich\af0\dbch\af31505\loch\f0 
John Smith, a 38-year-old man diagnosed with IBD in 2015, has undergone surgeries including a colectomy with colostomy, a colostomy takedown, and the creation of IPAA. Currently on biologic therapy, he has been treated with several medications in the past
\hich\af0\dbch\af31505\loch\f0 
, including Remicade, which he failed to respond to during a severe UC flare, and Entyvio, which was initiated post-operatively. For his pouchitis episodes, he has taken Cipro, Flagyl, Augmentin, VSL3, and Rifaximin, as well as being prescribed Mesalamine
\hich\af0\dbch\af31505\loch\f0 /b\hich\af0\dbch\af31505\loch\f0 
udesonide enemas. Currently, he experiences mild symptoms with 6-8 bowel movements daily, occasional blood, but no other severe symptoms. His most recent sigmoidoscopy in 2/2020 was hindered by a rectal stricture and showed persistent inflammation. (ChatG
\hich\af0\dbch\af31505\loch\f0 PT-4)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}}\pard \ltrpar\s30\ql \fi-360\li720\ri0\sa160\sl278\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls10\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
John Smith is a 38-year-old male with a history of colectomy and IPAA for severe ulcerative colitis (UC), with disease onset in 2015. He is currently on biologic therapy (Entyvio) but has previously failed Remicade and IV steroids due to lack of response,
\hich\af0\dbch\af31505\loch\f0 
 while Cipro and Flagyl were effective during episodes of pouchitis. His IBD is currently moderately active, as evidenced by persistent inflammation noted in recent sigmoidoscopies, with the most recent procedure on 2/2020 being incomplete due to a rectal
\hich\af0\dbch\af31505\loch\f0  s\hich\af0\dbch\af31505\loch\f0 tricture. He experiences 6-8 bowel movements daily, with occasional blood, but no abdominal pain or fevers. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 
The 38-year-old male patient has a 5-year history of Ulcerative Colitis (UC) with possible Crohn's disease of the pouch, dating back to 2015. He has undergone colectomy with colostomy in 2015 and colostomy takedown with creation of IPAA in 2017. Currently
\hich\af0\dbch\af31505\loch\f0 
, he is being managed with biologic therapy, Rifaximin, and Mesalamine/budesonide enemas, having previously failed Remicade and IV steroids due to lack of response, but responded to Cipro, Flagyl, Augmentin, and VSL3 for pouchitis treatment. His disease i
\hich\af0\dbch\af31505\loch\f0 s \hich\af0\dbch\af31505\loch\f0 
currently moderately active, characterized by 6-8 daily bowel movements with occasional blood, but no abdominal pain or fevers. Recent sigmoidoscopies have shown persistent diffuse inflammation, with the most recent attempt in February 2020 being incomple
\hich\af0\dbch\af31505\loch\f0 te due to a rectal stricture, and previous exams in October 2019 and January 2019 revealing inflammation in the pouch and pre-pouch ileum, indicating ongoing disease activity. (Llama-3.3)
\par }\pard\plain \ltrpar\ql \li360\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin360\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 9}{
\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}
{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par \hich\af0\dbch\af31505\loch\f0 Sophia Johnson is a 30-year-old woman with a known diagnosis of ulcerative colitis, who recently has been diagnosed with primary sclerosing cholangitis.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 IBD \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 2014 \hich\f0 \endash \loch\f0 
 Diagnosed with UC after presenting with bloody diarrhea on colonoscopy at Downtown Hospital. Report not available for review, but was told that it affected her whole colon. Started on Asacol. Bleeding resolved.
\par \hich\af0\dbch\af31505\loch\f0 2015 -Colonoscopy with mucosal healing, persistent proctitis affecting last 10cm of colon. Prescribed Canasa and hydrocortisone suppositories with improvement in diarrhea.
\par \hich\af0\dbch\af31505\loch\f0 2015-2020 \hich\f0 \endash \loch\f0 
 Did not follow up regularly with GI. Continued to have approximately 3-4 flares per year, usually managed with suppositories and other topical agents, never requiring hospitalization. PCP refilled her Asacol
\par \hich\af0\dbch\af31505\loch\f0 8/2020 \hich\f0 \endash \loch\f0 
 Hospitalized with nephrolithiasis and pyelonephritis; CT urogram with incidental finding of biliary dilation. Underwent MRCP concerning for possible PSC with irregularity of bile ducts, beaded appearance, no dominant stricture. LFTs normal.
\par \hich\af0\dbch\af31505\loch\f0 9/2021 \hich\f0 \endash \loch\f0  Referred to hepatology, established care with Dr. Sandoval for PSC.
\par \hich\af0\dbch\af31505\loch\f0 9/14/2021 \hich\f0 \endash \loch\f0  MRCP with stable appearance of bile ducts
\par \hich\af0\dbch\af31505\loch\f0 11/2021 \hich\f0 \endash \loch\f0 \hich\f0  First visit here to establish care. Was in the middle of \'93\loch\f0 \hich\f0 mini-flare\'94\loch\f0 
 having 5-8 watery bowel movements a day, trace blood, no urgency or tenesmus. Fecal calprotectin elevated 390
\par \hich\af0\dbch\af31505\loch\f0 12/2021 \hich\f0 \endash \loch\f0 
 Colonoscopy with severe proctitis affecting up to 5cm from anal verge. Rest of mucosa appeared normal. Random biopsies throughout the colon with no microscopic evidence of dysplasia. Started mesalamine/budesonide suppository.
\par \hich\af0\dbch\af31505\loch\f0 2/14/2022 \hich\f0 \endash \loch\f0  Started Entyvio
\par \hich\af0\dbch\af31505\loch\f0 8/2022 \hich\f0 \endash \loch\f0  Fecal calprotectin 144, improved from prior
\par \hich\af0\dbch\af31505\loch\f0 8/30/2022 \hich\f0 \endash \loch\f0  MRCP stable
\par \hich\af0\dbch\af31505\loch\f0 11/2022 \hich\f0 \endash \loch\f0  Colonoscopy with endoscopic healing, mild inflammation in the rectum Mayo 1 colitis
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (2/10/23)
\par \hich\af0\dbch\af31505\loch\f0 Had lots of stress at work, feels like it set off a flare. Having up to 7-9 BM per day, no blood. Took Canasa suppositories for a week and it\hich\f0 \rquote \loch\f0 
s better now, only having 4-5 BM daily which is her normal. No abdominal pain, bleeding, urgency or nocturnal sym\hich\af0\dbch\af31505\loch\f0 ptoms. 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2014
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \b\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls11\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Sophia Johnson is a 30-year-old woman with a known history of UC since 2014, stable on vedolizumab, who was recently diagnosed with primary sclerosing cholangitis. Her hepatologist is Dr. Sandoval. She has had significant improvement on endoscopy and with
\hich\af0\dbch\af31505\loch\f0 
 fecal calprotectin after starting Entyvio (started 2/14/2022). Her last colonoscopy shows persistent proctitis, but improved from prior. She still remains fairly symptomatic however. We have discussed possibly switching to another biologic but she is hes
\hich\af0\dbch\af31505\loch\f0 it\hich\af0\dbch\af31505\loch\f0 ant to do so at this time, saying her symptoms are overall manageable. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \b\kerning2\dbch\af31506\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31506\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
This 30-year-old female patient has been diagnosed with moderately active ulcerative colitis and primary sclerosing cholangitis since 2014. She has experienced recurrent flares, with a recent mini-flare characterized by 5-8 watery bowel movements per day,
 trace blood, and elevated fecal calprotectin. Her current medications include mesalamine/budesonide suppository and Entyvio, and she has previously responded well to Asacol and Canasa/hydrocortisone suppositories. However, she has failed to follow up reg
ul
arly and has not taken her medications consistently, leading to ongoing moderate disease activity. Recent endoscopic evaluations have shown severe proctitis and normal mucosa elsewhere, with stable appearance of bile ducts on MRCP. Currently, she is exper
iencing 4-5 bowel movements daily with no abdominal pain, bleeding, urgency, or nocturnal symptoms. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \b\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}\hich\af0\dbch\af31505\loch\f0 
Sophia Johnson, a 30-year-old woman, was diagnosed with ulcerative colitis in 2014, initially affecting her entire colon, but subsequent evaluations have shown \hich\af0\dbch\af31505\loch\f0 
proctitis in parts of the colon. Over the years, she has been treated with medications including Asacol, Canasa, hydrocortisone suppositories, mesalamine/budesonide suppositories, and is currently on Entyvio and Canasa suppositories. Despite these treatme
\hich\af0\dbch\af31505\loch\f0 
nts, her IBD remains mildly active, exacerbated recently by stress, leading to an increase in bowel movements which have somewhat improved with the use of Canasa suppositories. Her most recent colonoscopies in 2021 and 2022 indicated severe proctitis and 
\hich\af0\dbch\af31505\loch\f0 mi\hich\af0\dbch\af31505\loch\f0 
ld inflammation in the rectum, respectively. She has not undergone any IBD-related surgeries, and there are no mentions of results from flexible sigmoidoscopy or EGD/esophagogastroduodenoscopy. (ChatGPT-4)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \b\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
Sophia Johnson is a 30-year-old female diagnosed with ulcerative colitis (UC) in 2014, affecting her whole colon with persistent proctitis in the last 10 cm. She is currently on Entyvio, mesalamine/budesonide suppositories, and Canasa, having previously u
\hich\af0\dbch\af31505\loch\f0 
sed Asacol with improvement in symptoms. Her IBD is currently moderately active, with a recent episode characterized by 7-9 bowel movements daily, which improved to 4-5 after using Canasa. The most recent colonoscopy in 11/2022 showed endoscopic healing a
\hich\af0\dbch\af31505\loch\f0 nd\hich\af0\dbch\af31505\loch\f0  mild inflammation in the rectum. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \b\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 
The 30-year-old female patient has a 9-year history of ulcerative colitis, initially affecting the whole colon, with subsequent findings of persistent proctitis and severe proctitis affecting the last 10cm and up to 5cm from the anal verge, respectively. 
\hich\af0\dbch\af31505\loch\f0 
She has no defined history of previous surgeries. Her current IBD management includes mesalamine/budesonide suppository and Entyvio, having previously been treated with Asacol, Canasa, and hydrocortisone suppositories without reported failure. Despite rec
\hich\af0\dbch\af31505\loch\f0 en\hich\af0\dbch\af31505\loch\f0 
t flares, her current disease activity is active with mild symptoms, having improved with Canasa suppositories. Recent colonoscopies in 12/2021 and 11/2022 showed severe proctitis and endoscopic healing with mild inflammation, respectively, while an MRCP 
\hich\af0\dbch\af31505\loch\f0 in 8/2022 was stable; no flexible sigmoidoscopy or EGD/esophagogastroduodenoscopy results are available. (Llama-3.3)
\par }\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \column \hich\af0\dbch\af31505\loch\f0 Case 10}{
\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  }{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, \hich\af0\dbch\af31505\loch\f0 
thoroughness, relevancy, and fluency:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Sarah Thompson is a 25-year-old woman with hypothyroidism recently diagnosed with ulcerative colitis 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 4/2023 \hich\f0 \endash \loch\f0 
 Admitted to Green Valley Hospital with a history of prolonged diarrhea, rectal urgency, and 2 weeks of bloody stools. CTAP demonstrated evidence of colitis. C diff PCR negative. Flexible sigmoidoscopy revealed inflamed and ulcerated tissue up to 
\hich\af0\dbch\af31505\loch\f0 50cm from the anal verge which was the extent of exam. The patient received infliximab 5 mg/kg and was discharged on prednisone 40mg daily with taper.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 5/2023 \hich\f0 \endash \loch\f0  Seen in GI clinic, struggling with ongoing symptoms. Received 2}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\super\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 nd}{\rtlch\fcs1 \af0 
\ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
 but not third induction dose of infliximab. Referred back to the hospital after showing no significant improvement with ongoing biologic therapy and oral steroids. Infectious stool studies negative. Infliximab level 0 no antibodies. Received course of IV
\hich\af0\dbch\af31505\loch\f0  steroids and higher induction dose of infliximab 10mg/kg on 5/30/23 with improvement, then discharged again on steroid taper. Discussed possible surgical intervention at the time and\hich\af0\dbch\af31505\loch\f0 
 patient declined. 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (6/20/23)
\par \hich\af0\dbch\af31505\loch\f0 Continues on infliximab, received 5 mg/kg on 6/14/23. Currently 30mg of prednisone. Having 3-4 BM on good days, had one day in the last week when she had up to 10 BM however with blood in last few bowel movements. 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: 2023
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessments:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li720\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls12\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Sarah Thompson is a 25-year-old woman with newly diagnosed ulcerative pancolitis started on infliximab, currently on prednisone taper after \hich\af0\dbch\af31505\loch\f0 
hospitalization 5/2023, possibly in the setting of missing third induction dose. She continues to be symptomatic, although she\hich\f0 \rquote \loch\f0 
s improved from prior. She has not achieved therapeutic infliximab levels yet, but her ongoing symptoms are concerning for her b\hich\af0\dbch\af31505\loch\f0 
eing a non-responder. Will check level and antibodies. Given ongoing symptoms, will also plan to start azathioprine combination therapy. TPMT 5/16/23 showed she is a normal metabolizer. (Human)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \cf25\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\cf25\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Sarah Thompson, a 25-year-old female, was diagnosed with ulcerative colitis in 2023. Despite not having undergone any surgeries, her condition has been challenging to manage. Initially treated with an unspecified dose of infliximab and oral steroids, her 
\hich\af0\dbch\af31505\loch\f0 
disease did not respond significantly, leading to an escalated infliximab dose of 10mg/kg on 5/30/23. Currently, she is on a regimen of infliximab (5 mg/kg as of 6/14/23) and prednisone (30mg daily). Her disease activity remains moderately active, as evid
\hich\af0\dbch\af31505\loch\f0 en\hich\af0\dbch\af31505\loch\f0 
ced by fluctuating bowel movements, sometimes with blood. A flexible sigmoidoscopy performed in April 2023 revealed significant inflammation and ulceration in her colon. There are no records of EGD/esophagogastroduodenoscopy or colonoscopies. (ChatGPT-4)}
{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \cf26\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\cf26\chshdng0\chcfpat0\chcbpat23\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 
The 25-year-old female patient was diagnosed with ulcerative colitis in 2023, with no previous surgeries or medications for the disease. Currently, she is being treated with infliximab and prednisone, with a moderately active disease presentation and ongo
\hich\af0\dbch\af31505\loch\f0 
ing symptoms. Her most recent flexible sigmoidoscopy on 5/30/23 showed improvement, but there have been no recent EGD/esophagogastroduodenoscopy and colonoscopies. The patient has failed one induction dose of infliximab and is currently tapering off predn
\hich\af0\dbch\af31505\loch\f0 is\hich\af0\dbch\af31505\loch\f0 one. (Llama-2 13B)}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
The 25-year-old female patient has ulcerative colitis, with disease onset in 2023, characterized by inflamed and ulcerated tissue up to 50cm from the anal verge as seen on a recent flexible sigmoidoscopy. She is currently being managed with infliximab (5 
\hich\af0\dbch\af31505\loch\f0 
mg/kg, last dose on 6/14/23) and prednisone (30mg daily), having previously received initial doses of infliximab (5 mg/kg and 10mg/kg) and prednisone (40mg daily with taper) with limited significant improvement. The patient has no defined history of previ
\hich\af0\dbch\af31505\loch\f0 ou\hich\af0\dbch\af31505\loch\f0 
s surgeries. Her current disease activity is moderately active, with 3-4 bowel movements on good days and occasional episodes of up to 10 bowel movements with blood in stool. No recent EGD/esophagogastroduodenoscopy or colonoscopy results are available, b
\hich\af0\dbch\af31505\loch\f0 ut the flexible sigmoidoscopy findings inform her current treatment approach, aiming to control her symptoms and induce remission. (Llama-3.3)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}}\pard \ltrpar\s30\ql \fi-360\li720\ri0\sa160\sl278\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls12\adjustright\rin0\lin720\itap0\pararsid15621951\contextualspace {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Sarah Thompson is a 25-year-old female diagnosed with ulcerative colitis in 2023, presenting with inflamed and ulcerated tissue up to 50 cm from the anal verge. She is currently on infliximab, having received a dose of 5 mg/kg on 6/14/23, and is on a tape
\hich\af0\dbch\af31505\loch\f0 
ring regimen of prednisone at 30 mg daily. Despite two doses of infliximab, she showed no significant improvement initially and has experienced ongoing symptoms, with 3-4 bowel movements on good days and a recent increase to 10 bowel movements with blood.
\hich\af0\dbch\af31505\loch\f0  H\hich\af0\dbch\af31505\loch\f0 er IBD is currently moderately active. (ChatGPT-4o)
\par }\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \column }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 
\hich\af0\dbch\af31505\loch\f0 Case 11.}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par }\pard \ltrpar\qj \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Given the following history of present illness, please rate the assessment of the case in terms of its accuracy, thoroughness, relevancy, and fluency:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par 
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 HPI:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Today, I saw Jennifer Walker in the GI clinic in consultation regarding biologic therapy for her UC with associated primary sclerosing cholangitis.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Jennifer Walker is a 52-year-old woman with diagnosis of ulcerative colitis and primary sclerosing cholangitis.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 History:
\par \hich\af0\dbch\af31505\loch\f0 5/2023 \hich\f0 \endash \loch\f0 
 Jennifer was diagnosed with UC following symptoms of abdominal pain, frequent diarrhea, and bloody stools. Her initial diagnosis was confirmed at Palmsdale Presbyterian Hospital after CTAP showed extensive colitis. Flexible sigmoidoscopy revealed
\hich\af0\dbch\af31505\loch\f0  Mayo 3 colitis up to 35cm from the anal verge. She was started on infliximab 10mg/kg and experienced symptom relief.
\par \hich\af0\dbch\af31505\loch\f0 6/2023 \hich\f0 \endash \loch\f0  Jennifer was noted to have elevated liver enzymes during a routine follow-up, subsequent MRCP confirmed the diagnosis of primary sclerosing cholangitis. 
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Today (7/25/23)
\par \hich\af0\dbch\af31505\loch\f0 
Jennifer reports some relief in her UC symptoms. She does not have any more diarrhea, abdominal pain, bloody stools. She denies urgency, nocturnal symptoms, tenesmus, or unintentional weight loss. She expresses concern over her recent diagnosis of PSC. Sh
\hich\af0\dbch\af31505\loch\f0 e continues on infliximab and ursodeoxycholic acid.
\par \hich\af0\dbch\af31505\loch\f0  
\par \hich\af0\dbch\af31505\loch\f0 Disease onset: UC - 2023; PSC - 2023
\par \hich\af0\dbch\af31505\loch\f0  
\par }{\rtlch\fcs1 \ab\af0 \ltrch\fcs0 \b\f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Assessment:}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 1.\tab}}\pard\plain \ltrpar
\s30\ql \fi-360\li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\ls2\adjustright\rin-20\lin-20\itap0\pararsid15621951\contextualspace \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 Jennifer Walker is a \hich\af0\dbch\af31505\loch\f0 
52-year-old woman recently diagnosed with left sided ulcerative colitis and PSC (diagnosis 2023). Her most recent flexible sigmoidoscopy 5/2023 showed Mayo 3 colitis up to 35cm from the anal verge. She started infliximab with improvement in symptoms. She 
\hich\af0\dbch\af31505\loch\f0 
had elevated LFTs noted around 6/2023 and MRCP showed evidence of PSC. We will reassess disease activity with labwork and eventual colonoscopy in a few months. Her liver disease will need close monitoring, she will need referral to hepatology. (Human)

\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \cf26\kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 2.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\cf26\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Jennifer Walker, a 52-year-old female, was diagnosed with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) in 2023. She has experienced relief in her UC symptoms but has active PSC, as evidenced by elevated liver enzymes. She has been on i
\hich\af0\dbch\af31505\loch\f0 nfliximab and ursodeoxycholic acid and has not undergone any surgeries or endoscopic procedures. Her current disease activity is characterized by active PSC and relief in UC symptoms. (Llama-2 13B)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 3.\tab}}{\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 
Jennifer Walker, a 52-year-old woman, was diagnosed with Ulcerative Colitis (UC) and Primary Sclerosing Cholangitis (PSC) in 2023. Her UC, characterized by Mayo 3 colitis extending up to 35cm from the anal verge, was identified through a flexible sigmoido
\hich\af0\dbch\af31505\loch\f0 
scopy performed in May 2023. Currently, she is managing her UC effectively with Infliximab (10mg/kg) and has reported significant symptom relief. Additionally, she is taking Ursodeoxycholic acid for PSC. There are no prior surgeries or previous IBD medica
\hich\af0\dbch\af31505\loch\f0 ti\hich\af0\dbch\af31505\loch\f0 ons mentioned in her history, and her UC symptoms are currently well-controlled. Information about any EGD/Esophagogastroduodenoscopy or colonoscopies, if any, is not provided. (ChatGPT-4)

\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 4.\tab}\hich\af0\dbch\af31505\loch\f0 
Jennifer Walker is a 52-year-old female diagnosed with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) in 2023. She presents with Mayo 3 colitis affecting up to 35 cm from the anal verge. Currently, her UC is well-controlled; she reports 
\hich\af0\dbch\af31505\loch\f0 
no diarrhea, abdominal pain, or bloody stools, and is on infliximab (10 mg/kg) and ursodeoxycholic acid. Her initial diagnosis was confirmed in May 2023 following symptoms of abdominal pain and bloody stools, and a flexible sigmoidoscopy at that time reve
\hich\af0\dbch\af31505\loch\f0 al\hich\af0\dbch\af31505\loch\f0 ed the extent of her colitis. She expresses concern regarding her recent PSC diagnosis. (ChatGPT-4o)
\par {\listtext\pard\plain\ltrpar \s30 \rtlch\fcs1 \af0 \ltrch\fcs0 \kerning2\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0 5.\tab}\hich\af0\dbch\af31505\loch\f0 
The patient, a 52-year-old female, has been diagnosed with Ulcerative Colitis (UC) with associated primary sclerosing cholangitis (PSC), which onset in 2023. Her UC is currently well-controlled, with no recent symptoms of diarrhea, abdominal pain, or bloo
\hich\af0\dbch\af31505\loch\f0 
dy stools, and she is being managed with Infliximab and Ursodeoxycholic acid. A flexible sigmoidoscopy performed in 5/2023 showed Mayo 3 colitis up to 35cm from the anal verge, but results of any EGD/esophagogastroduodenoscopy or colonoscopies are not ava
\hich\af0\dbch\af31505\loch\f0 il\hich\af0\dbch\af31505\loch\f0 
able. There is no record of previous surgeries or failed IBD medications, as this information is not defined. Overall, the patient's UC appears to be effectively managed with her current treatment regimen, although ongoing monitoring and evaluation will b
\hich\af0\dbch\af31505\loch\f0 e necessary to assess the long-term efficacy of her treatment and the progression of her PSC.\~\~(Llama-3.3)
\par }\pard\plain \ltrpar\ql \li0\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin0\itap0\pararsid15621951 \rtlch\fcs1 \af31507\afs24\alang1025 \ltrch\fcs0 
\fs24\lang1033\langfe1042\kerning2\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1042 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li-20\ri-20\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin-20\lin-20\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 \hich\af0\dbch\af31505\loch\f0  
\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0\pararsid15621951 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\insrsid15621951\charrsid14615927 
\par }\pard \ltrpar\ql \li0\ri0\sa160\sl278\slmult1\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 {\rtlch\fcs1 \af0 \ltrch\fcs0 \f0\lang1024\langfe1024\noproof\insrsid15621951\charrsid15621951 
\par }{\*\themedata 504b030414000600080000002100e9de0fbfff0000001c020000130000005b436f6e74656e745f54797065735d2e786d6cac91cb4ec3301045f748fc83e52d4a
9cb2400825e982c78ec7a27cc0c8992416c9d8b2a755fbf74cd25442a820166c2cd933f79e3be372bd1f07b5c3989ca74aaff2422b24eb1b475da5df374fd9ad
5689811a183c61a50f98f4babebc2837878049899a52a57be670674cb23d8e90721f90a4d2fa3802cb35762680fd800ecd7551dc18eb899138e3c943d7e503b6
b01d583deee5f99824e290b4ba3f364eac4a430883b3c092d4eca8f946c916422ecab927f52ea42b89a1cd59c254f919b0e85e6535d135a8de20f20b8c12c3b0
0c895fcf6720192de6bf3b9e89ecdbd6596cbcdd8eb28e7c365ecc4ec1ff1460f53fe813d3cc7f5b7f020000ffff0300504b030414000600080000002100a5d6
a7e7c0000000360100000b0000005f72656c732f2e72656c73848fcf6ac3300c87ef85bd83d17d51d2c31825762fa590432fa37d00e1287f68221bdb1bebdb4f
c7060abb0884a4eff7a93dfeae8bf9e194e720169aaa06c3e2433fcb68e1763dbf7f82c985a4a725085b787086a37bdbb55fbc50d1a33ccd311ba548b6309512
0f88d94fbc52ae4264d1c910d24a45db3462247fa791715fd71f989e19e0364cd3f51652d73760ae8fa8c9ffb3c330cc9e4fc17faf2ce545046e37944c69e462
a1a82fe353bd90a865aad41ed0b5b8f9d6fd010000ffff0300504b0304140006000800000021006b799616830000008a0000001c0000007468656d652f746865
6d652f7468656d654d616e616765722e786d6c0ccc4d0ac3201040e17da17790d93763bb284562b2cbaebbf600439c1a41c7a0d29fdbd7e5e38337cedf14d59b
4b0d592c9c070d8a65cd2e88b7f07c2ca71ba8da481cc52c6ce1c715e6e97818c9b48d13df49c873517d23d59085adb5dd20d6b52bd521ef2cdd5eb9246a3d8b
4757e8d3f729e245eb2b260a0238fd010000ffff0300504b03041400060008000000210094a9528694070000c7200000160000007468656d652f7468656d652f
7468656d65312e786d6cec595f8b1bc9117f0fe43b0cf32e6b66248da4c5f2a1bfdeb3776d63c90ef7d82bb566dadb333d4cb7762d8e83e07bca4b207077e421
0779cb430839c8418ebce4c3186c92cb874875cf68d42db5bc7f30c184dd7dd1b47e55fd9baaeaaa52f5fdcf5e27d4b9c039272cedb9fe3dcf75703a670b9246
3df7c56c52ebb80e17285d20ca52dc73d798bb9f3df8e52feea32311e3043b209ff223d4736321b2a37a9dcf6119f17b2cc3297cb7647982043ce6517d91a34b
d09bd07ae079613d4124759d1425a0f6e97249e6d8994995ee838df23185c75470b930a7f954aac68684c22ece7d89e06b3ea4b9738168cf857d16ec72865f0b
d7a1880bf8a2e77aeacfad3fb85f4747a51015076435b989fa2be54a81c579a0f6cca3b36a536f1c749a7ea55f01a8d8c78d3bf2bfd2a700683e87372db8e83a
fd56e8758212ab818a8f16ddddb6df30f19afec61e67bf1b0e82a6a15f810afdcd3dbc37e98e472d03af4005beb587ef7bc1a0db30f00a54e0c33d7c73dc6f07
6303af403125e9f93e3a6c773a6189ae204b468fadf06e187aed5109dfa2201aaae8925b2c592a0ec55a825eb17c020009a44890d411eb0c2fd11ca2b89f09c6
9d11e119456bd7c950ca382c7b81ef43e835bda0fa571647471869d2921730e17b4b928fc3e739c944cf7d045a5d0df2eea79fdebef9f1ed9bbfbffdfaebb76f
feea9c902816852a43ee18a5912ef7f39f7ef79fef7fedfcfb6f7ffcf99b6fed78aee3dfffe537effff1cf0fa987a3b635c5bbef7e78ffe30fef7effdb7ffdf9
1b8bf67e8ece74f88c24983b4ff0a5f39c25f082ca14267f7c96df4c621623a24bf4d388a314c95d2cfac72236d04fd688220b6e804d3bbecc21d5d8800f57af
0cc2d3385f0962d1f8384e0ce0296374c072ab151ecbbd3433cf566964df3c5fe9b8e7085dd8f61ea2d4f0f27895418e253695c3181b349f51940a14e1140b47
7ec7ce31b6bcdd178418763d25f39c71b614ce17c419206235c98c9c19d1b4153a2609f8656d2308fe366c73fad219306a7beb11be3091703610b5909f616a98
f1215a0994d854ce504275839f2011db484ed7f95cc78db9004f47983267bcc09cdb649ee6f0be9ad31f23c86e56b79fd27562227341ce6d3a4f10633a72c4ce
87314a321b764ad258c77ececf214491f38c091bfc949927443e831f507ad0dd2f0936dc7d75367801594ea7b40d10f9cd2ab7f8f2216646fc4ed77489b02dd5
f4f3c448b1fd9c58a363b08a8cd03ec198a24bb4c0d879f1b985c1806586cdb7a41fc590558eb12db01e213356e5738a39f44ab2b9d9cf9327841b213bc5113b
c0e774bd9378d6284d507e48f313f0ba6ef3f1590e87d142e1299d9febc027047a408817ab519e72d0a105f741adcf62641430f9ccedf1bace0dff5de78cc1b9
7c65d0b8c6b904197c631948ecbacc076d3343d4d8601b3033449c135bba0511c3fd5b11595c95d8ca2ab7340fedd60dd01d194d4f42d22b3aa0ff5de703fdc5
bb3f7c6f09c18fd3edd8151ba9ea867dcea15472bcd3dd1cc2edf63443962fc8a7dfd28cd02a7d86a18aece7abbb8ee6aea371ffef3b9a43e7f9ae8f39d46ddc
f5312ef417777d4c395af9387dccb67581ae468e178a318f1afa2407673e4b42e954ac293ee16aecc3e1d7cc62028b524ecd3b713503cc62f828cb1c6c60e0a2
1c29192767e25744c4d31865301bf25da924e2a5ea883b19e3303252cb56dd124f57c9295b14a34e355bf28acaca91d8ae7b2d183a15eb30a612053a6c978b92
9f9aa7025fc5365263d60d01297b1312da6626898685447bb37805093935fb382cba16161da97ee3aa3d5300b5ca2bf073db811fe93db7d594846046cee7d09a
2fa49f0a576fbcab9cf9313d7dc8984604c058b1781318ca579eee4aae075f4fbe5d116ad7f0b4414239a5082b9384b28c6af0780c3f82cbe894abd7a171535f
77b72e35e84953a8fd20beb734da9d0fb1b8adaf416e3737d054cf1434752e7b6ed86841c8cc51d673973032868f4906b1c3e52f2e4423b877998bbc38f0b7c9
2c59cec508f1b830b84a3a857b122270ee5092f45cf9fa951b68aa7288e2e60790103e59725d482b9f1a3970bae964bc5ce2b9d0ddaead484b178f90e18b5c61
fd5689df1e2c25d90adc3d8d1797ce195de5cf118458abed4b032e08879b03bfb0e682c0555895c8b6f1b75398cae4afdf45a9182ad611cd625456143d991770
554f2a3aeaa9b281f654be33185433495908cf22596075a31ad5b42a5d05878355f76a2169392d696e6ba6915564d5b4673163874d19d8b1e5ed8abcc66a6362
c8697a852f52f76ecaed6e72dd4e9f505509307865bfdb957e8dda7633839a64bc9f8665ce2e57cddab179c12ba85da74868593fdca8ddb15b5523acdbc1e2ad
2a3fc8ed462d2c2d377da5b2b4ba33d7afb5d9d92b481e23e872575470e54a98ebe608bab2a9ea498ab40147e4b5288f067c725639e9b95f7aad7e7318b48635
afd31ad79a8da657ebb4fa8d5abfd56af8e396ef8d06c1575058449cf8ade2be7e02d717745ddedaabf5bd9bfb647343736fce923a5337f375455cdddcfbc1e1
9b7b8740d2f93218fbcda01f0c6bc3911fd69ac128ac75da8d7e6d1884a3a00f293d9cf4bf729d0b05f607a3d164d20a6ae110704dafdfaaf5078d612dec8c07
c1c41f37471e80cbccf91afa6fb0e9c616f051f17af05f000000ffff0300504b0304140006000800000021000dd1909fb60000001b010000270000007468656d
652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73848f4d0ac2301484f78277086f6fd3ba109126dd88d0add40384e4350d
363f2451eced0dae2c082e8761be9969bb979dc9136332de3168aa1a083ae995719ac16db8ec8e4052164e89d93b64b060828e6f37ed1567914b284d26245228
2e3198720e274a939cd08a54f980ae38a38f56e422a3a641c8bbd048f7757da0f19b017cc524bd62107bd5001996509affb3fd381a89672f1f165dfe514173d9
850528a2c6cce0239baa4c04ca5bbabac4df000000ffff0300504b01022d0014000600080000002100e9de0fbfff0000001c0200001300000000000000000000
000000000000005b436f6e74656e745f54797065735d2e786d6c504b01022d0014000600080000002100a5d6a7e7c0000000360100000b000000000000000000
00000000300100005f72656c732f2e72656c73504b01022d00140006000800000021006b799616830000008a0000001c00000000000000000000000000190200
007468656d652f7468656d652f7468656d654d616e616765722e786d6c504b01022d001400060008000000210094a9528694070000c720000016000000000000
00000000000000d60200007468656d652f7468656d652f7468656d65312e786d6c504b01022d00140006000800000021000dd1909fb60000001b010000270000
00000000000000000000009e0a00007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73504b050600000000050005005d010000990b00000000}
{\*\colorschememapping 3c3f786d6c2076657273696f6e3d22312e302220656e636f64696e673d225554462d3822207374616e64616c6f6e653d22796573223f3e0d0a3c613a636c724d
617020786d6c6e733a613d22687474703a2f2f736368656d61732e6f70656e786d6c666f726d6174732e6f72672f64726177696e676d6c2f323030362f6d6169
6e22206267313d226c743122207478313d22646b3122206267323d226c743222207478323d22646b322220616363656e74313d22616363656e74312220616363
656e74323d22616363656e74322220616363656e74333d22616363656e74332220616363656e74343d22616363656e74342220616363656e74353d22616363656e74352220616363656e74363d22616363656e74362220686c696e6b3d22686c696e6b2220666f6c486c696e6b3d22666f6c486c696e6b222f3e}
{\*\latentstyles\lsdstimax376\lsdlockeddef0\lsdsemihiddendef0\lsdunhideuseddef0\lsdqformatdef0\lsdprioritydef99{\lsdlockedexcept \lsdqformat1 \lsdpriority0 \lsdlocked0 Normal;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 1;
\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 2;\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 3;\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 4;
\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 5;\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 6;\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 7;
\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 8;\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 9;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 1;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 5;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 6;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 7;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 8;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index 9;
\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 1;\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 2;\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 3;
\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 4;\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 5;\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 6;
\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 7;\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 8;\lsdsemihidden1 \lsdunhideused1 \lsdpriority39 \lsdlocked0 toc 9;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Normal Indent;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 footnote text;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 annotation text;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 header;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 footer;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 index heading;\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority35 \lsdlocked0 caption;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 table of figures;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 envelope address;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 envelope return;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 footnote reference;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 annotation reference;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 line number;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 page number;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 endnote reference;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 endnote text;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 table of authorities;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 macro;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 toa heading;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Bullet;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Number;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List 3;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List 5;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Bullet 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Bullet 3;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Bullet 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Bullet 5;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Number 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Number 3;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Number 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Number 5;\lsdqformat1 \lsdpriority10 \lsdlocked0 Title;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Closing;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Signature;\lsdsemihidden1 \lsdunhideused1 \lsdpriority1 \lsdlocked0 Default Paragraph Font;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text Indent;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Continue;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Continue 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Continue 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Continue 4;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 List Continue 5;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Message Header;\lsdqformat1 \lsdpriority11 \lsdlocked0 Subtitle;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Salutation;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Date;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text First Indent;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text First Indent 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Note Heading;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text Indent 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Body Text Indent 3;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Block Text;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Hyperlink;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 FollowedHyperlink;\lsdqformat1 \lsdpriority22 \lsdlocked0 Strong;
\lsdqformat1 \lsdpriority20 \lsdlocked0 Emphasis;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Document Map;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Plain Text;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 E-mail Signature;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Top of Form;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Bottom of Form;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Normal (Web);\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Acronym;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Address;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Cite;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Code;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Definition;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Keyboard;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Preformatted;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Sample;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Typewriter;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 HTML Variable;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Normal Table;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 annotation subject;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 No List;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Outline List 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Outline List 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Outline List 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Simple 1;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Simple 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Simple 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Classic 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Classic 2;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Classic 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Classic 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Colorful 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Colorful 2;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Colorful 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Columns 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Columns 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Columns 3;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Columns 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Columns 5;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 2;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 5;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 6;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 7;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Grid 8;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 2;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 4;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 5;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 6;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 7;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table List 8;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table 3D effects 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table 3D effects 2;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table 3D effects 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Contemporary;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Elegant;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Professional;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Subtle 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Subtle 2;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Web 1;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Web 2;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Web 3;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Balloon Text;\lsdpriority39 \lsdlocked0 Table Grid;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Table Theme;\lsdsemihidden1 \lsdlocked0 Placeholder Text;
\lsdqformat1 \lsdpriority1 \lsdlocked0 No Spacing;\lsdpriority60 \lsdlocked0 Light Shading;\lsdpriority61 \lsdlocked0 Light List;\lsdpriority62 \lsdlocked0 Light Grid;\lsdpriority63 \lsdlocked0 Medium Shading 1;\lsdpriority64 \lsdlocked0 Medium Shading 2;
\lsdpriority65 \lsdlocked0 Medium List 1;\lsdpriority66 \lsdlocked0 Medium List 2;\lsdpriority67 \lsdlocked0 Medium Grid 1;\lsdpriority68 \lsdlocked0 Medium Grid 2;\lsdpriority69 \lsdlocked0 Medium Grid 3;\lsdpriority70 \lsdlocked0 Dark List;
\lsdpriority71 \lsdlocked0 Colorful Shading;\lsdpriority72 \lsdlocked0 Colorful List;\lsdpriority73 \lsdlocked0 Colorful Grid;\lsdpriority60 \lsdlocked0 Light Shading Accent 1;\lsdpriority61 \lsdlocked0 Light List Accent 1;
\lsdpriority62 \lsdlocked0 Light Grid Accent 1;\lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 1;\lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 1;\lsdpriority65 \lsdlocked0 Medium List 1 Accent 1;\lsdsemihidden1 \lsdlocked0 Revision;
\lsdqformat1 \lsdpriority34 \lsdlocked0 List Paragraph;\lsdqformat1 \lsdpriority29 \lsdlocked0 Quote;\lsdqformat1 \lsdpriority30 \lsdlocked0 Intense Quote;\lsdpriority66 \lsdlocked0 Medium List 2 Accent 1;\lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 1;
\lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 1;\lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 1;\lsdpriority70 \lsdlocked0 Dark List Accent 1;\lsdpriority71 \lsdlocked0 Colorful Shading Accent 1;\lsdpriority72 \lsdlocked0 Colorful List Accent 1;
\lsdpriority73 \lsdlocked0 Colorful Grid Accent 1;\lsdpriority60 \lsdlocked0 Light Shading Accent 2;\lsdpriority61 \lsdlocked0 Light List Accent 2;\lsdpriority62 \lsdlocked0 Light Grid Accent 2;\lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 2;
\lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 2;\lsdpriority65 \lsdlocked0 Medium List 1 Accent 2;\lsdpriority66 \lsdlocked0 Medium List 2 Accent 2;\lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 2;\lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 2;
\lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 2;\lsdpriority70 \lsdlocked0 Dark List Accent 2;\lsdpriority71 \lsdlocked0 Colorful Shading Accent 2;\lsdpriority72 \lsdlocked0 Colorful List Accent 2;\lsdpriority73 \lsdlocked0 Colorful Grid Accent 2;
\lsdpriority60 \lsdlocked0 Light Shading Accent 3;\lsdpriority61 \lsdlocked0 Light List Accent 3;\lsdpriority62 \lsdlocked0 Light Grid Accent 3;\lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 3;\lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 3;
\lsdpriority65 \lsdlocked0 Medium List 1 Accent 3;\lsdpriority66 \lsdlocked0 Medium List 2 Accent 3;\lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 3;\lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 3;\lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 3;
\lsdpriority70 \lsdlocked0 Dark List Accent 3;\lsdpriority71 \lsdlocked0 Colorful Shading Accent 3;\lsdpriority72 \lsdlocked0 Colorful List Accent 3;\lsdpriority73 \lsdlocked0 Colorful Grid Accent 3;\lsdpriority60 \lsdlocked0 Light Shading Accent 4;
\lsdpriority61 \lsdlocked0 Light List Accent 4;\lsdpriority62 \lsdlocked0 Light Grid Accent 4;\lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 4;\lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 4;\lsdpriority65 \lsdlocked0 Medium List 1 Accent 4;
\lsdpriority66 \lsdlocked0 Medium List 2 Accent 4;\lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 4;\lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 4;\lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 4;\lsdpriority70 \lsdlocked0 Dark List Accent 4;
\lsdpriority71 \lsdlocked0 Colorful Shading Accent 4;\lsdpriority72 \lsdlocked0 Colorful List Accent 4;\lsdpriority73 \lsdlocked0 Colorful Grid Accent 4;\lsdpriority60 \lsdlocked0 Light Shading Accent 5;\lsdpriority61 \lsdlocked0 Light List Accent 5;
\lsdpriority62 \lsdlocked0 Light Grid Accent 5;\lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 5;\lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 5;\lsdpriority65 \lsdlocked0 Medium List 1 Accent 5;\lsdpriority66 \lsdlocked0 Medium List 2 Accent 5;
\lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 5;\lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 5;\lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 5;\lsdpriority70 \lsdlocked0 Dark List Accent 5;\lsdpriority71 \lsdlocked0 Colorful Shading Accent 5;
\lsdpriority72 \lsdlocked0 Colorful List Accent 5;\lsdpriority73 \lsdlocked0 Colorful Grid Accent 5;\lsdpriority60 \lsdlocked0 Light Shading Accent 6;\lsdpriority61 \lsdlocked0 Light List Accent 6;\lsdpriority62 \lsdlocked0 Light Grid Accent 6;
\lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 6;\lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 6;\lsdpriority65 \lsdlocked0 Medium List 1 Accent 6;\lsdpriority66 \lsdlocked0 Medium List 2 Accent 6;
\lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 6;\lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 6;\lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 6;\lsdpriority70 \lsdlocked0 Dark List Accent 6;\lsdpriority71 \lsdlocked0 Colorful Shading Accent 6;
\lsdpriority72 \lsdlocked0 Colorful List Accent 6;\lsdpriority73 \lsdlocked0 Colorful Grid Accent 6;\lsdqformat1 \lsdpriority19 \lsdlocked0 Subtle Emphasis;\lsdqformat1 \lsdpriority21 \lsdlocked0 Intense Emphasis;
\lsdqformat1 \lsdpriority31 \lsdlocked0 Subtle Reference;\lsdqformat1 \lsdpriority32 \lsdlocked0 Intense Reference;\lsdqformat1 \lsdpriority33 \lsdlocked0 Book Title;\lsdsemihidden1 \lsdunhideused1 \lsdpriority37 \lsdlocked0 Bibliography;
\lsdsemihidden1 \lsdunhideused1 \lsdqformat1 \lsdpriority39 \lsdlocked0 TOC Heading;\lsdpriority41 \lsdlocked0 Plain Table 1;\lsdpriority42 \lsdlocked0 Plain Table 2;\lsdpriority43 \lsdlocked0 Plain Table 3;\lsdpriority44 \lsdlocked0 Plain Table 4;
\lsdpriority45 \lsdlocked0 Plain Table 5;\lsdpriority40 \lsdlocked0 Grid Table Light;\lsdpriority46 \lsdlocked0 Grid Table 1 Light;\lsdpriority47 \lsdlocked0 Grid Table 2;\lsdpriority48 \lsdlocked0 Grid Table 3;\lsdpriority49 \lsdlocked0 Grid Table 4;
\lsdpriority50 \lsdlocked0 Grid Table 5 Dark;\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful;\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful;\lsdpriority46 \lsdlocked0 Grid Table 1 Light Accent 1;\lsdpriority47 \lsdlocked0 Grid Table 2 Accent 1;
\lsdpriority48 \lsdlocked0 Grid Table 3 Accent 1;\lsdpriority49 \lsdlocked0 Grid Table 4 Accent 1;\lsdpriority50 \lsdlocked0 Grid Table 5 Dark Accent 1;\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful Accent 1;
\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful Accent 1;\lsdpriority46 \lsdlocked0 Grid Table 1 Light Accent 2;\lsdpriority47 \lsdlocked0 Grid Table 2 Accent 2;\lsdpriority48 \lsdlocked0 Grid Table 3 Accent 2;
\lsdpriority49 \lsdlocked0 Grid Table 4 Accent 2;\lsdpriority50 \lsdlocked0 Grid Table 5 Dark Accent 2;\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful Accent 2;\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful Accent 2;
\lsdpriority46 \lsdlocked0 Grid Table 1 Light Accent 3;\lsdpriority47 \lsdlocked0 Grid Table 2 Accent 3;\lsdpriority48 \lsdlocked0 Grid Table 3 Accent 3;\lsdpriority49 \lsdlocked0 Grid Table 4 Accent 3;
\lsdpriority50 \lsdlocked0 Grid Table 5 Dark Accent 3;\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful Accent 3;\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful Accent 3;\lsdpriority46 \lsdlocked0 Grid Table 1 Light Accent 4;
\lsdpriority47 \lsdlocked0 Grid Table 2 Accent 4;\lsdpriority48 \lsdlocked0 Grid Table 3 Accent 4;\lsdpriority49 \lsdlocked0 Grid Table 4 Accent 4;\lsdpriority50 \lsdlocked0 Grid Table 5 Dark Accent 4;
\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful Accent 4;\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful Accent 4;\lsdpriority46 \lsdlocked0 Grid Table 1 Light Accent 5;\lsdpriority47 \lsdlocked0 Grid Table 2 Accent 5;
\lsdpriority48 \lsdlocked0 Grid Table 3 Accent 5;\lsdpriority49 \lsdlocked0 Grid Table 4 Accent 5;\lsdpriority50 \lsdlocked0 Grid Table 5 Dark Accent 5;\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful Accent 5;
\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful Accent 5;\lsdpriority46 \lsdlocked0 Grid Table 1 Light Accent 6;\lsdpriority47 \lsdlocked0 Grid Table 2 Accent 6;\lsdpriority48 \lsdlocked0 Grid Table 3 Accent 6;
\lsdpriority49 \lsdlocked0 Grid Table 4 Accent 6;\lsdpriority50 \lsdlocked0 Grid Table 5 Dark Accent 6;\lsdpriority51 \lsdlocked0 Grid Table 6 Colorful Accent 6;\lsdpriority52 \lsdlocked0 Grid Table 7 Colorful Accent 6;
\lsdpriority46 \lsdlocked0 List Table 1 Light;\lsdpriority47 \lsdlocked0 List Table 2;\lsdpriority48 \lsdlocked0 List Table 3;\lsdpriority49 \lsdlocked0 List Table 4;\lsdpriority50 \lsdlocked0 List Table 5 Dark;
\lsdpriority51 \lsdlocked0 List Table 6 Colorful;\lsdpriority52 \lsdlocked0 List Table 7 Colorful;\lsdpriority46 \lsdlocked0 List Table 1 Light Accent 1;\lsdpriority47 \lsdlocked0 List Table 2 Accent 1;\lsdpriority48 \lsdlocked0 List Table 3 Accent 1;
\lsdpriority49 \lsdlocked0 List Table 4 Accent 1;\lsdpriority50 \lsdlocked0 List Table 5 Dark Accent 1;\lsdpriority51 \lsdlocked0 List Table 6 Colorful Accent 1;\lsdpriority52 \lsdlocked0 List Table 7 Colorful Accent 1;
\lsdpriority46 \lsdlocked0 List Table 1 Light Accent 2;\lsdpriority47 \lsdlocked0 List Table 2 Accent 2;\lsdpriority48 \lsdlocked0 List Table 3 Accent 2;\lsdpriority49 \lsdlocked0 List Table 4 Accent 2;
\lsdpriority50 \lsdlocked0 List Table 5 Dark Accent 2;\lsdpriority51 \lsdlocked0 List Table 6 Colorful Accent 2;\lsdpriority52 \lsdlocked0 List Table 7 Colorful Accent 2;\lsdpriority46 \lsdlocked0 List Table 1 Light Accent 3;
\lsdpriority47 \lsdlocked0 List Table 2 Accent 3;\lsdpriority48 \lsdlocked0 List Table 3 Accent 3;\lsdpriority49 \lsdlocked0 List Table 4 Accent 3;\lsdpriority50 \lsdlocked0 List Table 5 Dark Accent 3;
\lsdpriority51 \lsdlocked0 List Table 6 Colorful Accent 3;\lsdpriority52 \lsdlocked0 List Table 7 Colorful Accent 3;\lsdpriority46 \lsdlocked0 List Table 1 Light Accent 4;\lsdpriority47 \lsdlocked0 List Table 2 Accent 4;
\lsdpriority48 \lsdlocked0 List Table 3 Accent 4;\lsdpriority49 \lsdlocked0 List Table 4 Accent 4;\lsdpriority50 \lsdlocked0 List Table 5 Dark Accent 4;\lsdpriority51 \lsdlocked0 List Table 6 Colorful Accent 4;
\lsdpriority52 \lsdlocked0 List Table 7 Colorful Accent 4;\lsdpriority46 \lsdlocked0 List Table 1 Light Accent 5;\lsdpriority47 \lsdlocked0 List Table 2 Accent 5;\lsdpriority48 \lsdlocked0 List Table 3 Accent 5;
\lsdpriority49 \lsdlocked0 List Table 4 Accent 5;\lsdpriority50 \lsdlocked0 List Table 5 Dark Accent 5;\lsdpriority51 \lsdlocked0 List Table 6 Colorful Accent 5;\lsdpriority52 \lsdlocked0 List Table 7 Colorful Accent 5;
\lsdpriority46 \lsdlocked0 List Table 1 Light Accent 6;\lsdpriority47 \lsdlocked0 List Table 2 Accent 6;\lsdpriority48 \lsdlocked0 List Table 3 Accent 6;\lsdpriority49 \lsdlocked0 List Table 4 Accent 6;
\lsdpriority50 \lsdlocked0 List Table 5 Dark Accent 6;\lsdpriority51 \lsdlocked0 List Table 6 Colorful Accent 6;\lsdpriority52 \lsdlocked0 List Table 7 Colorful Accent 6;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Mention;
\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Smart Hyperlink;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Hashtag;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Unresolved Mention;\lsdsemihidden1 \lsdunhideused1 \lsdlocked0 Smart Link;}}{\*\datastore }}